APPLICATOR CONFIGURED FOR THE ADMINISTRATION OF A SKIN IMPROVEMENT COMPOSITION TO A SUBJECT'S SK

专利摘要:
applicator configured for administering a skin improvement composition to a skin and/or subcutis of a subject, use of a microneedle and method for manufacturing a microneedle the present invention provides, namely, applicators comprising an array of microneedles for the administering a composition comprising a biocompatible ceramic material effective in improving skin. in particular, the applicators and methods of the present invention aim to fill in the lines, wrinkles, depressed scars, and creases of the subject's skin and restore youthful filling to the skin.
公开号:BR112015005073B1
申请号:R112015005073-5
申请日:2013-06-13
公开日:2021-06-01
发明作者:Amir Avraham
申请人:Amir Avraham；
IPC主号:

专利说明:

field of invention
[0001] The present invention is related to applicators, comprising an array of microneedles for the administration of a composition comprising a biocompatible ceramic material effective in improving skin, and their methods of use. In particular, the devices and methods of the present invention aim to fill in the lines, wrinkles, depressed scars, and folds of the subject's skin and restore youthful filling to the skin. Fundamentals of Invention
[0002] The skin is composed of the epidermis and the dermis. Below these layers is the hypodermis, which is not generally classified as a layer of skin. The hypodermis is also commonly referred to as the subcutaneous fat layer, subcutis or subcutaneous tissue. The outermost epidermis is made up of stratified squamous epithelium with an underlying basement membrane. It does not contain blood vessels and is fed by diffusion from the dermis. The epidermis is mainly composed of keratinocytes, with melanocytes and Langerhans cells also present. This layer of skin acts as a barrier between the body and the external environment, keeping water in the body and preventing the penetration of harmful chemicals and pathogens.
[0003] The dermis lies below the epidermis and contains a number of structures including blood vessels, nerves, hair follicles, smooth muscle, glands and lymphatic tissue. The dermis (or chorion) is usually 0.1-3 mm thick and is the main component of human skin. It is composed of a network of connective tissue, predominantly collagen fibrils providing support and elastin fibers providing flexibility. The main cell types making up the dermis are fibroblasts, adipocytes (fat storage) and macrophages.
[0004] The hypodermis lies below the dermis and is important for attaching the skin to underlying muscle and bone, as well as supplying them with blood vessels and nerves. The hypodermis is made up of loose connective tissue and elastin and contains fibroblasts, macrophages and adipocytes. Adipocytes play a major role in the fat storage function of the hypodermis. Fat serves as a filling material and isolating the body from the external environment.
[0005] Facial aging occurs as a result of several factors, among them are inherent changes within the skin, the effects of gravity, activity of facial muscles, leading to the formation of dynamic lines, loss or change of skin, bone loss, loss of skin. tissue elasticity and exposure to adverse environmental conditions, particularly the sun or ultraviolet radiation and pollutants. The skin ages when the epidermis begins to thin, causing the junction with the dermis to flatten out. Collagen decreases as a person ages and the collagen bundles, which give the skin its turgor, become looser and lose strength. When the skin loses its elasticity, it is less able to resist stretching. Along with gravity, the pulling action of muscles and tissue changes, the skin begins to wrinkle. Loss of water and depletion of cell connections also reduces the skin's barrier function, which can cause the skin's pore size to increase.
[0006] Efforts are made to develop and use compositions to correct skin defects such as scars and wrinkles, or to augment a subject's tissue in order to improve the appearance of the skin, particularly facial skin.
[0007] Currently, there are dozens of dermal fillers known for skin improvement that include autologous implantable materials, allogeneic products, xenogenic products and synthetically derived products. Available dermal fillers include natural biodegradable substances (such as collagen, gelatin, hyaluronic acid, dextran and dry acellular particle dermal matrix), biodegradable synthetic polymers (such as poly-L-lactic acid, polyethylene oxide and carboxymethylcellulose), non-synthetic polymers -biodegradables (such as polymethyl methacrylate, polyacrylamide, polyalkylimide and silicones) and combinations thereof.
[0008] Biocompatible ceramic skin enhancing materials, such as hydroxyapatite, are known as efficient skin enhancing materials due to their properties:
[0009] Hydroxyapatite (Ca53(PO4)(OH)) is a naturally occurring mineral form of calcium phosphate. Hydroxyapatite comprises the mineral constituent of bones, thus making it biocompatible and non-immunogenic when introduced into a subject's body. Of note, hydroxyapatite is biodegradable following the same metabolic pathways as bone fragments resulting from common bone fractures, however, it is semi-permanent as it lasts up to 3 years when implanted in a subject. Furthermore, when injected as small microspheres, hydroxyapatite acts as a support structure that promotes the formation of new tissue similar to its surrounding environment. Inside skins such as the dermis, deposited particles of Hydroxyapatite support fibroblastic ingrowth and new collagen formation (Jacovella, PF, Clin. Interv. Aging., 2008, 3(1): 161-174, SuchanekW. and Yoshimura M., J. Mater. Res., 1997, 13(1): 94-117).
[0010] International Publication No. WO/1993/016657 discloses injectable ceramic implant compositions for soft and hard tissue repair and improvement thereof.
US Patent No. 7,655,250 discloses a composition for application to the skin, comprising hydroxyapatite particles tuned as an absorbency enhancing material.
[0012] US Patent Application 2011/0125288 discloses particles of a biocompatible ceramic material in a gel carrier. The biocompatible ceramic material can be hydroxylapatite, polystyrene, polymethylmethacrylate, glass and stainless steel. Skin enhancement products are usually injected with a needle just below the surface of the skin, in place of the wrinkle, line, or fold (or scar or subcutaneous tissue to be reinforced). Essentially, the products fill under the upper layers of the skin. Some skin improvement products are implanted under the skin through an incision. In either case, the skin is cut or pierced with a needle or a scalpel-like instrument to insert skin improvement products into the spot! desired, and therefore the procedure is performed by a trained medical professional. Application of dermal fillers, by injection or implantation is uncomfortable and possibly painful for the subject and, in addition, requires the labor of a highly trained medical professional.
[0013] International Publication No. WO 2008/072229 discloses a device and methods for delivering dermal filler compositions to the skin of a subject using a microneedle device.
[0014] US Patent No. 0 8,167,852 discloses a microneedle device that includes microneedles that can be inserted into the skin and dissolve or dilate in the skin.
[0015] Thus, it is desirable to have highly efficient means for painless self-administration of long-lasting skin improvement products. Summary of the invention
[0016] The present invention is related to a device comprising an array of microneedles and a skin enhancing composition useful for augmenting skin in a subject. In particular, the device of the invention is useful for filling in lines, wrinkles, depressed scars and unwanted folds of a subject's skin. According to the invention, microneedles advantageously comprise at least one biocompatible ceramic material which is injected into the dermis layer (or lower layers) of a subject's skin and remains there for an extended period of time, inducing a filling effect. According to some embodiments, microneedles comprising the biocompatible ceramic material are urged into the dermis layer (or lower layers) of a subject's skin. According to some embodiments, only the sharp point section of each microneedle skeleton and the middle part of the microneedle comprising the enhancement composition are driven into the dermis layer (or lower layers) of the subject's skin. According to some modalities, following the removal of the microneedles from the subject, the biocompatible ceramic material remains embedded within the treated area for at least several months, preferably more than a year. Each possibility represents a separate embodiment of the present invention.
[0017] As used in this document, the term "biocompatible ceramic soft tissue enhancement material", "biocompatible ceramic material" and "biocompatible ceramic" are used interchangeably.
[0018] According to some embodiments, the present invention responds to the need for devices for self-administration of a skin improvement composition, which are highly efficient, easy to use, cause minimal discomfort to the treated subject and do not require a professional trained doctor. The devices of the invention are capable of providing homogeneous improvement of lines, wrinkles, depressed scars and skin folds, thus resulting in a substantially smooth skin surface that can be difficult to obtain through injection or transplantation, especially in fine wrinkles.
[0019] According to one aspect, the present invention provides an applicator configured for administering a skin improving composition to a skin and/or subcutis of a subject, the applicator comprising a substrate, wherein the substrate has a a flat structure generally having two opposing surfaces, one surface intended to be placed proximally on a subject's skin and the other surface facing away from the subject's skin; and a microneedle array, wherein the microneedle array is located on the proximal surface of the subject's skin, the array comprising a multiplicity of microneedles, each of the microneedles comprising: a skeleton made of a rigid material, the skeleton comprising : a sharp point section, located at one of the ends of said skeleton, said sharp point section, being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin enhancement composition comprising at least one biocompatible ceramic material, wherein said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharpened section is greater than a diameter of said enhancement composition. .
According to some embodiments, the applicator is configured for administering a skin improvement composition to a skin of a subject or subcutaneous layers of a subject or a combination thereof. Each possibility represents a separate embodiment of the present invention.
[0021] According to another aspect, the present invention provides a microneedle for administering a skin improvement composition to a skin and/or subcutis of a subject, the microneedle comprising: a skeleton made of a rigid material, the skeleton comprising: a sharp-pointed section located at one end of said skeleton, said sharp-pointed section, being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin enhancement composition comprising at least one biocompatible ceramic material, wherein said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharpened section is greater than a diameter of said enhancement composition. .
[0022] According to some embodiments, the microneedle is configured for administering a skin improvement composition to a skin of a subject or subcutaneous layers of a subject or a combination thereof. Each possibility represents a separate embodiment of the present invention. According to another aspect, the present invention provides a method for filling a crease, crease, line or depressed area in the skin of and/or subcutis of a subject, comprising placing in place of the crease, crease, line or depressed area an applicator configured for administering a skin improving composition to a skin and/or subcutis of a subject, the applicator comprising a substrate, wherein the substrate has a generally flat structure having two opposing surfaces, wherein one surface is intended to be placed proximally on a subject's skin and the other surface facing away from the subject's skin; and a microneedle array, wherein the microneedle array is located on the proximal surface of the subject's skin, the array comprising a multiplicity of microneedles, each of the microneedles comprising: a skeleton made of a rigid material, the skeleton comprising : a sharp point section, located at one of the ends of said skeleton, said sharp point section, being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin enhancement composition comprising at least one biocompatible ceramic material, wherein said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharpened section is greater than a diameter of said enhancement composition. .
[0023] According to some embodiments, the method of the invention provides filling an unwanted crease, wrinkle, line or depressed area in a subject's skin or in a subject's subcutaneous layers in a combination thereof. Each possibility represents a separate embodiment of the present invention.
[0024] According to some modalities, the length of the base is equal to or greater than the thickness of the epidermis in a treated area. Each possibility represents a separate embodiment of the present invention. In some embodiments, the skeletal base of the microneedle does not comprise the skin enhancing composition. In some embodiments, a base having a length equal to or greater than the thickness of the epidermis in the treated area prevents delivery of the skin enhancing composition to the epidermis. According to some embodiments, the length of said base is variable in correlation with the location where each microneedle is configured to be located in a treated area. It should be noted that, according to some embodiments, an applicator configured to be placed in a treated area having an epidermis of varying levels of thickness may comprise microneedles having bases of different lengths corresponding to different levels of thickness. According to some embodiments, the length of the base is variable in correlation with the depth of the skin or subcutaneous layer to be treated by the microneedle. In accordance with some embodiments, microneedles configured to deliver the skin enhancing composition of the invention to a deep layer of skin and/or subcutaneously have a longer base than microneedles configured to deliver the composition to a shallower layer of skin. . According to some embodiments, an applicator configured to deliver the skin improving composition of the invention to skin or subcutaneous layers of different depths comprises microneedles having bases of different lengths, in correlation with the depth of the skin or subcutaneous layer to be treated by each microneedle. Each possibility represents a separate embodiment of the present invention.
[0025] According to some embodiments, the present invention provides a method for filling an unwanted crease, crease, line or depressed area in a subject, comprising placing the applicator of the invention in place of the crease, crease, line or depressed area. In some embodiments, the present invention provides an applicator in accordance with the present invention for use in filling an unwanted crease, wrinkle, line, or depressed area in a subject's skin. In some embodiments, unwanted crease, wrinkle, line, or depressed area refers to unwanted crease, wrinkle, line, or depressed area in a subject's skin or a subject's subcutis or a combination thereof. Each possibility represents a separate embodiment of the present invention.
[0026] According to some embodiments, the biocompatible ceramic material is a calcium phosphate ceramic material. According to some embodiments, the biocompatible ceramic material is hydroxyapatite. According to some embodiments, the biocompatible ceramic material is biodegradable. In some embodiments, the biocompatible ceramic material is in the form of particles. According to some embodiments, the biocompatible ceramic material particles are up to a size of 100 micrometers. In some embodiments, the biocompatible ceramic material particles are about 10 to 100 micrometers, preferably about 40 micrometers. Each possibility represents a separate embodiment of the present invention.
[0027] According to some embodiments, the enhancement composition comprises a biodegradable carrier. According to some embodiments, the biodegradable carrier is selected from the group consisting of: a salt, a biodegradable polymer, and a combination thereof. According to some embodiments, the biodegradable polymer is a polymer selected from the group consisting of: polyethylene glycol, Polyglactin 910, Polyglecapron 25, Polydioxanone, Lactomer 9-1, Glycomer 631, Polyglyconate and a combination thereof. According to some embodiments, the salt is selected from the group consisting of: sodium sulfate, sodium chloride, magnesium sulfate, magnesium citrate, magnesium chloride and a combination thereof. In some embodiments, the biodegradable carrier comprises magnesium sulfate and polyethylene glycol. In some embodiments, the enhancer composition comprises hydroxyapatite particles, magnesium sulfate and polyethylene glycol.
[0028] According to some embodiments, the enhancement composition comprises at least one type of skin filler material. According to many embodiments, the skin enhancing material is selected from the group consisting of: a biodegradable natural substance, a biodegradable synthetic polymer, a non-biodegradable synthetic polymer, a non-biodegradable natural substance, and combinations thereof. Each possibility represents a separate embodiment of the present invention.
[0029] According to some modalities, a natural biodegradable substance is selected, for example, from the group consisting of: bovine collagen, porcine collagen, recombinant collagen, human collagen, gelatin, hyaluronic acid, hyaluronic acid derivative, dermal matrix of dry acellular particles, allogeneic fat and their combinations. Each possibility represents a separate embodiment of the present invention.
[0030] According to some embodiments, a synthetic biodegradable polymer is selected, for example, from the group consisting of: poly-L-lactic acid, polyethylene oxide, Carboxymethylcellulose and their combinations. Each possibility represents a separate embodiment of the present invention.
[0031] According to some embodiments, a non-biodegradable synthetic polymer is selected, for example, from the group consisting of: polymethyl methacrylate, polymethyl methacrylate granules, silicones, silicone rubbers, expanded polytetrafluoroethylene, polyacrylamide, polyalkylimide and its combinations. Each possibility represents a separate embodiment of the present invention.
[0032] According to some embodiments, the enhancement composition additionally comprises a biologically active agent selected from a group consisting of: an enzyme, a drug, a toxin and a combination thereof. Each possibility represents a separate embodiment of the present invention. In some embodiments, the toxin is botulinum toxin. In some embodiments, the toxin is a derivative of botulinum toxin. According to some modalities, the drug is selected from the group consisting of: an analgesic, a drug for the treatment of pathological scars and a combination thereof, according to some modalities, the drug is an analgesic. According to some modalities, the medicine for the treatment of pathological scars is a corticosteroid.
[0033] According to some embodiments, the enhancing composition additionally comprises a medical pigment.
[0034] According to some embodiments, the substrate is flexible. In some embodiments, the applicator comprises a plurality of segments, the segments being configured to flexibly move relative to one another. According to some embodiments, each segment comprises a substrate and an array of microneedles. According to some modalities, the shape of the applicator is adaptable to the external lines of a skin that needs improvement. According to some modalities, the substrate is curved.
[0035] According to some embodiments, at least a part of each microneedle is substantially composed of the enhancement composition. In some embodiments, the enhancement composition is within at least a part of each microneedle. According to some embodiments, the microneedles are at least in part coated with the enhancement composition. In some embodiments, the enhancement composition, at least in part, surrounds the midsection of the microneedle skeleton.
[0036] According to some modalities, the rigid material is selected from the group consisting of: metal, plastic, a ceramic material, silicone and a combination thereof. Each possibility represents a separate embodiment of the present invention. In some embodiments, the rigid material is a metal. According to some modalities, the metal is selected from the group consisting of: stainless steel, titanium, iron, gold, silver, platinum and a combination thereof. Each possibility represents a separate embodiment of the present invention.
[0037] According to some modalities, the sharp point section, the base section and the middle section of the skeleton form integrally. According to some modalities, the sharp point section has a shape selected from the group consisting of: a cone, a pyramid, a triangular pyramid and a polygonal pyramid. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the diameter of the sharpened section at its widest part is greater than the diameter of the middle part of the microneedle at its widest part. In some embodiments, the middle part of the microneedle is the part of the microneedle comprised between the sharp point section of the microneedle skeleton and the base of the microneedle skeleton. According to some embodiments, the middle part of the microneedle comprises the middle part of the microneedle skeleton and the enhancement composition. According to some embodiments, the middle part of the microneedle comprises the middle section of the skeleton microneedle, at least part of the pour restrictor and the enhancement composition. In some embodiments, the midsection of the skeleton is a longitudinal core extending substantially from the center of the sharpened section to the center of the base.
[0038] According to some embodiments, the skeleton additionally comprises a leakage restrictor situated between the sharp point section and the intermediate section. In some embodiments, the leak restrictor is configured to prevent leakage of the subject's skin enhancing composition after extraction of the microneedle from the subject's skin. According to some embodiments, the leak restrictor is integrally formed with the sharp point section. According to some modalities, the leakage restrictor is in a shape selected from the group consisting of: a cone, a pyramid, a triangular pyramid and a polygonal pyramid. Each possibility represents a separate embodiment of the present invention. Under some arrangements, the major part of the leak restrictor is turned towards the widest part of the sharp end section.
[0039] According to some modalities, the base of the skeleton has a format selected from the group consisting of: a cylinder, a rectangular box, a cuboid, a triangular box and a polygonal box. Each possibility represents a separate embodiment of the present invention.
[0040] According to some embodiments, the skeleton is attached to the surface of the substrate intended to be placed proximally to a subject's skin. According to some embodiments, the skeleton is integrally formed with said substrate surface intended to be placed proximally on a subject's skin. In some embodiments, the skeleton is at least partially inserted into the substrate.
[0041] According to some embodiments, the enhancement composition comprises at least 30% biocompatible ceramic material. In some embodiments, the skin enhancing composition comprises hydroxyapatite particles, magnesium sulfate and polyethylene glycol. According to some modalities, the applicator is in a form selected from the group consisting of: a strip and a flap. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the applicator is in the form of a strip. A strap is currently a preferred modality as it allows for more precise placement than other configurations.
[0042] According to some embodiments, the microneedle array is located on at least a portion of the surface of the substrate, intended to be placed proximally on the skin of a subject. In some embodiments, at least part of the substrate surface intended to be placed proximally to a subject's skin is an adhesive surface.
[0043] According to some arrangements, the applicator is configured for self-application. According to some modalities, the applicator is disposable after a single use. In some embodiments, at least part of the applicator is substantially transparent. In accordance with some embodiments, the applicator additionally comprises a marking indicating the location of the microneedle array on the substrate.
[0044] According to some modalities, the microneedles are configured for the delivery of the enhancement composition. According to some embodiments, the length of the microneedles is from 0.05 mm to 1 mm. According to further embodiments, the length of the microneedles of the invention is up to 2 mm. According to some embodiments, the length of the microneedles is variable in correlation with the location of the microneedles in the substrate.
[0045] Other modalities, features, advantages and the full scope of applicability of the present invention will become apparent in the detailed description and figures provided hereinafter. However, it should be understood that the detailed description, while indicating preferred embodiments of the invention, is given by way of illustration only, as various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art a from this detailed description. BRIEF DESCRIPTION OF THE FIGURES
[0046] FIG. 1a schematically shows an applicator, according to some embodiments of the invention, in the form of a flap.
[0047] FIG. 1B shows a cross section along line A-A of the applicator of Fig. 1A, in accordance with some embodiments of the invention.
[0048] FIG. 2a schematically shows an applicator, according to some embodiments of the invention, in the form of a strip with several segments.
[0049] FIG. 2B shows a cross section along line B-B of the applicator of Fig. 2B, in accordance with some embodiments of the invention.
[0050] FIG. 3 schematically shows an applicator, according to some embodiments of the invention, in the form of a flap, comprising microneedles of varying degrees of thickness and having markings indicating the location of the microneedles in the applicator.
[0051] FIGs. 4A-C schematically show microneedles, in accordance with some embodiments of the invention.
[0052] FIG. 4D shows a cross section along line C-C of the applicator of Fig. 4A, in accordance with some embodiments of the invention.
[0053] FIG. 4E shows a cross section along line D-D of the applicator of Fig. 4A, in accordance with some embodiments of the invention.
[0054] FIGs. 5A-C schematically show microneedles, in accordance with some embodiments of the invention.
[0055] FIGs. 6A-D schematically show the application of an applicator to a line or deep skin deficiency, in accordance with some embodiments of the invention.
[0056] FIGs. 7A-D schematically show the application of an applicator to a line or shallow skin deficiency, in accordance with some embodiments of the invention.
[0057] FIGs. 8 A-E schematically show a process for manufacturing microneedles, according to some embodiments of the invention. DETAILED DESCRIPTION OF THE INVENTION
[0058] The present invention provides, for the first time, a microneedle-based applicator for delivering a skin-improving composition to the skin of a subject, the composition comprising at least one biocompatible ceramic material. The applicators of the invention provide an efficient, comfortable and easy to use delivery system for skin improvement compositions. The present invention further provides methods of delivering the skin enhancing compositions to the skin of a subject. The methods of the invention make it possible, inter alia, to fill in unwanted folds, wrinkles or lines in a subject's skin. In some embodiments, the methods of the invention allow a subject to use the methods and applicators of the invention without the assistance of a trained medical professional. According to other embodiments, the applicators of the invention may be provided as disposable strips or patches. Each possibility represents a separate embodiment of the present invention.
[0059] According to one aspect, the present invention provides an applicator configured for administering a skin improving composition to a skin and/or subcutis of a subject, the applicator comprising a substrate, wherein the substrate has a a flat structure generally having two opposing surfaces, one surface intended to be placed proximally on a subject's skin and the other surface facing away from the subject's skin; and a microneedle array, wherein the microneedle array is located on the proximal surface of the subject's skin, the array comprising a multiplicity of microneedles, each of the microneedles comprising: a skeleton made of a rigid material, the skeleton comprising : a sharp point section, located at one of the ends of said skeleton, said sharp point section, being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin enhancement composition comprising at least one biocompatible ceramic material, wherein said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharpened section is greater than a diameter of said enhancement composition. .
[0060] According to another aspect, the present invention provides a microneedle for administering a skin improving composition to a skin of a subject, the microneedle comprising: a skeleton made of a rigid material, the skeleton comprising: a section sharp point, located at one end of said skeleton, said sharp point section, being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin enhancement composition comprising at least one biocompatible ceramic material, wherein said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharpened section is greater than a diameter of said enhancement composition. .
[0061] According to some embodiments, the applicator and/or the microneedle of the invention are configured for administering a skin improvement composition to a skin of a subject or subcutaneous layers of a subject or a combination thereof. Each possibility represents a separate embodiment of the present invention.
According to some embodiments, the term "skin improvement" refers to increasing the volume of the skin and/or subcutis to be treated. In some embodiments, the term "skin improvement" refers to increasing the apparent volume of treated skin.
[0063] According to some modalities, the substrate is in a form selected from the group consisting of: a strip and a flap. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the substrate is in the form of a strip. According to some incarnations, the substrate is in the form of a patch. A strap is currently a preferred modality as it allows for more precise placement than other configurations.
[0064] As used herein, the term "strip" refers to a longitudinal shape, having a first end and a second end. In some embodiments, the substrate comprises a first surface, intended to be proximal to the skin, and a second surface, facing away from the skin. As used herein, the term "proximal" refers to a side that is close to a subject's skin. As used herein, the term "proximal side" and "proximal portion" are interchangeable. In some embodiments, the terms "the proximal surface", "the surface intended to be placed proximally to a subject's skin" and "the inner surface" are used interchangeably. As used herein, the terms "patient" and "subject" are used interchangeably.
[0065] According to some embodiments, the microneedles are located on at least part of the proximal surface of the substrate. In some embodiments, at least a portion of the proximal surface of the substrate is composed of an adhesive. In some embodiments, the microneedles are not co-located with the adhesive on the proximal surface of the substrate. According to some embodiments, the microneedles are co-located with the adhesive on the proximal surface of the substrate. In some embodiments, the microneedles are at least in part co-located with the adhesive on the proximal surface of the substrate. As used herein, the term "co-located" refers to being situated at the same two-dimensional coordinates.
[0066] According to some embodiments, the substrate is flexible. According to some modalities, the applicator is adaptable to the outer lines of a skin that needs improvement. According to some modalities, the substrate is adaptable to the outer lines of a skin that needs improvement. In a non-limiting example, the applicator of the invention can be applied to the face of a subject such that it conforms to the outer lines and contours of the face. Applying the flexible applicator to a subject's face such that the applicator conforms to the outer lines of the face can allow for the efficient delivery of skin enhancing composition to the desired location. According to some modalities, the applicator is curved. According to some modalities, the applicator is curved in order to adapt to the outer lines of a skin that needs improvement.
[0067] According to some embodiments, the applicator is composed of a plurality of segments. Under some modalities, segments are configured to move flexibly in relation to each other. In accordance with some embodiments, each segment comprises an array of microneedles comprising the skin enhancing composition of the invention. In accordance with some embodiments, each segment comprises a substrate and an array of microneedles comprising the skin enhancing composition of the invention. According to other embodiments, the applicator comprises a plurality of segments and a single array of microneedles. According to some modalities, the segments are connected to each other. According to some modalities, the segments are formed integrally with each other. An applicator comprising a plurality of segments configured to flexibly move relative to one another can allow for precise placement of the applicator over the unwanted lines, wrinkles, depressed scars or creases to be treated. Under some modalities, the size and/or number of segments varies in order to allow precise placement of the applicator over the lines, wrinkles, depressed scars or folds to be treated. Each possibility represents a separate embodiment of the present invention. According to some modalities, the applicator is composed of segments of different sizes. As used herein, the terms "a plurality of" and "a multiplicity of" are used interchangeably and refer to at least two. As used herein, the terms "made of" and "composed of" are used interchangeably. In accordance with some embodiments, the applicator additionally comprises a removable shield or cap or liner configured to protect the microneedles prior to insertion into a subject.
[0068] According to some modalities, the applicator can be of any shape and size. According to some embodiments, the substrate can be of any shape and size. According to other embodiments, the applicator is of a shape and size, enabling the efficient delivery of a skin enhancing composition to a subject in need thereof. In some embodiments, the applicator is of a shape and size that correspond to a subject's treatment areas. Non-limiting examples are strips, which may correspond to longitudinal lines or wrinkles, and flaps which may correspond to larger skin folds, depressed scars or defects to be treated.
[0069] According to other embodiments, different applicators according to the invention may comprise different amounts of skin improving composition. Under some embodiments, different microneedles within the same applicator make up a different amount of skin enhancing composition. According to other embodiments, different applicators of the invention may include different numbers of microneedles. According to some embodiments, the microneedles comprised in the applicators of the inventions can be arranged in different conformations. According to some embodiments, the microneedles comprised in the applicators of the invention can be of different sizes. According to some embodiments, the microneedles comprised in the applicator of the invention are arranged as a single array. According to some embodiments, the microneedles comprised in the applicator of the invention are arranged as several arrays. According to some embodiments, the microneedles comprised in the applicator of the invention are arranged as several arrays, each array being composed in a different segment of the applicator. According to some embodiments, the spacing between every 2 microneedles in the same microneedle array is between 0.1-2 mm. According to some embodiments, the spacing between every 2 microneedles in the same microneedle array is at least 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0, 8, 0.9, 1, 1.2, 1.4, 1.6, 1.8, 2 mm. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the spacing between every 2 microneedles in the same microneedle array is at least spacing that allows flexibility of the applicator of the invention and/or the adaptability of the applicator to the outer lines of a skin in need of improvement. Each possibility represents a separate embodiment of the present invention.
[0070] As used herein, the term "biodegradable" refers to a material that is naturally degraded when in a subject's body, by enzymatic activity, chemical dissolution, or otherwise. to a material that does not cause any systemic or local toxic and/or undesirable effects when administered to a subject.
[0071] According to some embodiments, the substrate can be of any material known in the art, as long as it is capable of supporting microneedles and a skin-improving composition. According to some embodiments, the substrate is made of a non-biodegradable material. According to some embodiments, the substrate is made of a rigid material. Non-limiting examples of materials suitable for making the substrate are: a metal, a polymer, medical plastic, a rubber, latex, or a combination thereof. Each possibility represents a separate embodiment of the present invention. Suitable polymers for making the applicator may include, for example, polyethylene terephthalate, polyvinylchloride, polyethylene, polypropylene, polycarbonate, polyester and so on. In some embodiments, at least part of the substrate is made of a rigid material. In some embodiments, at least part of the substrate is made of a flexible material.
[0072] According to some embodiments, the substrate and the base of the microneedles are made of a non-biodegradable material. As used herein, microneedle base refers to the base of the microneedle skeleton. According to some embodiments, the microneedle skeleton and at least part of the substrate are made of a non-biodegradable material. In some embodiments, the base of the microneedles and at least part of the substrate are made of a unitary piece of non-biodegradable material. In some embodiments, the base of the microneedles and at least part of the substrate are integrally formed. In some embodiments, the microneedle skeleton and at least part of the substrate are made of a unitary piece of non-biodegradable material. In some embodiments, the microneedle skeleton and at least part of the substrate are integrally formed. In some embodiments, the microneedle skeleton is integrally formed with at least part of the substrate surface intended to be placed proximally to a subject's skin. In some embodiments, the microneedle skeleton is attached to the substrate. In some embodiments, the microneedle skeleton is attached to the surface of the substrate to be placed proximally to a subject's skin. In some embodiments, the microneedle skeleton is at least partially inserted into the substrate. In accordance with some embodiments, microneedles having a skeleton at least partially inserted into the applicator substrate are more stably attached to the substrate than microneedles that are attached and/or formed integrally with the substrate. Each possibility represents a separate embodiment of the present invention.
[0073] According to some embodiments, the intermediate section of the microneedle skeleton passes through a tight opening in the base of the skeleton and is at least partially inserted into the substrate or the substrate surface intended to be placed proximally to a subject's skin . Each possibility represents a separate embodiment of the present invention. In some embodiments, the mid-section of the microneedle skeleton passes through a tight opening in the base of the skeleton and is at least partially inserted into the substrate or substrate surface intended to be placed proximally to a subject's skin. that the middle section is perpendicular to the base and the substrate. Each possibility represents a separate embodiment of the present invention.
[0074] According to some embodiments, the intermediate part of the microneedle is the part of the microneedle comprised between the sharp point section of the microneedle skeleton and the base of the microneedle skeleton, comprising the intermediate section of the microneedle skeleton and the composition of improvement. According to some embodiments, only the middle part of the microneedle comprises the skin enhancing composition. In some embodiments, the sharp-tipped section of the microneedle skeleton does not contain the skin-enhancing composition. In some embodiments, the skeletal base of the microneedle does not contain the skin enhancing composition.
[0075] According to some modalities, the applicator is configured to be applied by a medical professional. According to some modalities, the applicator is configured for self-application. It should be understood that a subject may be able to use the applicator and methods of the invention without the help of a trained medical professional. According to some modalities, the applicator is disposable after a single use. According to some embodiments, upon removal of the applicator from the subject's skin, the applicator is substantially devoid of blood or other substances that present biological hazards after use of the applicator. As used herein, "substantially devoid" means devoid, apart from trace amounts.
[0076] According to some embodiments, at least part of the applicator is substantially transparent. In some embodiments, at least part of the substrate is substantially transparent. In some embodiments, only the portion of the applicator comprising the microneedles is substantially transparent. In some embodiments, only the portion of the substrate comprising the microneedles is substantially transparent. In some embodiments, at least the portion of the substrate not comprising an adhesive surface is substantially transparent. As used herein, "substantially transparent" refers to a material having a level of opacity that allows one to see the skin being treated through the material. Using an applicator comprising a substrate that is substantially transparent, in accordance with the present invention, can allow to see the location of the skin defect or deficiency through the applicator and thus allow for accurate applicator placement. In some embodiments, at least a part of the substrate and/or at least part of the microneedles is substantially transparent. Each possibility represents a separate embodiment of the present invention.
[0077] According to some embodiments, at least part of each microneedle is substantially transparent. In some embodiments, at least part of the microneedle skeleton is substantially transparent. In some embodiments, the microneedle skeleton is substantially transparent. In some embodiments, at least the base of the microneedles is substantially transparent. In some embodiments, at least the base of the microneedles and a portion of the substrate are substantially transparent. In some embodiments, at least a portion of the substrate is substantially transparent and the microneedles are not substantially transparent. Under some embodiments, clearly visible microneedles which are not substantially transparent, comprised of a substantially transparent substrate in accordance with the invention, aid in precisely placing the applicator in place of the skin defect or deficiency.
[0078] According to some embodiments, the applicator additionally comprises a marking indicating the location of the microneedle array on the substrate. In some embodiments, the marking indicating the location of the microneedle array on the substrate is on the substrate surface facing away from the skin. In some embodiments, the marking indicating the location of the microneedle array on the substrate is on the surface proximal to the skin. In some embodiments, the marking indicating the location of the microneedle array on the substrate is both on the substrate surface facing away from the skin and on the substrate surface proximal to the skin. In some embodiments, the marking is in the form of dots or the like, each dot representing the location of a single microneedle in the microneedle array. In some embodiments, the marking delimits the general location of the entire microneedle array on the substrate. According to some modalities, marking indicating the location of the microneedle array on the substrate assists in accurately placing the applicator over the location of the defect or skin deficiency, thus delivering the skin improvement composition to the exact location of the defect or skin deficiency.
[0079] Non-limiting examples of a skin defect or deficiency, according to some embodiments of the present invention, are selected from the group consisting of: lines, wrinkles, folds, depressed scars, undesirable areas of skin or subcutaneous deficiency or a combination of these. Each possibility represents a separate embodiment of the present invention.
[0080] As used herein, the terms "composition", "the composition of the invention", "improvement composition", "a soft tissue enhancing composition" and "skin enhancing composition" are used interchangeably and refer to to a composition comprising at least one biocompatible ceramic skin-improving material. It should be understood that a skin enhancing composition according to the present invention is suitable for filling skin, subcutis or a combination thereof.
[0081] As used in this document, the term "biocompatible ceramic skin enhancement material", "biocompatible ceramic soft tissue enhancement material", "biocompatible ceramic agent", "biocompatible ceramic" and "biocompatible ceramic material" " are used interchangeably. As used herein, the term "biocompatible ceramic material" refers to biocompatible skin enhancing material having ceramic properties. According to some embodiments, the biocompatible ceramic material is an inorganic ceramic material, such as, but not limited to, hydroxyapatite. According to some embodiments, the biocompatible ceramic material is not soluble in water. According to some embodiments, the biocompatible ceramic material is a calcium phosphate ceramic material. According to some embodiments, the biocompatible ceramic material is hydroxyapatite. As used herein, the terms "hydroxyapatite", "hydroxylapatite", "calcium hydroxyapatite" and "calcium hydroxylapatite" are interchangeable. According to some embodiments, hydroxyapatite as used herein refers to a salt or derivative of hydroxyapatite.
[0082] A non-limiting example of a skin improving composition comprising a biocompatible ceramic material is RADIESSE ® manufactured by Merz Aesthetics, composed of calcium hydroxyapatite granules suspended in a gel carrier consisting primarily of water, glycerin and sodium carboxymethylcellulose.
[0083] According to some embodiments, a biocompatible ceramic material is biodegradable. According to some embodiments, a biocompatible ceramic material is capable of biodegrading not less than 1, 2, 3, 4 weeks after administration to a subject. Each possibility represents a separate embodiment of the present invention. According to some embodiments, a biocompatible ceramic material is capable of biodegrading not less than 1, 2, 3, 4, 5, 6, 7,8, 9, 10, 11, 12 months after administration to a subject. Each possibility represents a separate embodiment of the present invention. According to some embodiments, a biocompatible ceramic material is capable of biodegrading not less than 0.5, 1, 2, 3, 4 years after administration to a subject. Each possibility represents a separate embodiment of the present invention. Under some embodiments, a biocompatible ceramic material is capable of biodegrading not less than 12 months after administration to a subject.
[0084] According to some modalities, the biodegradation of a biocompatible ceramic material is significantly slower than the biodegradation of skin improvement materials selected from the group consisting of: bovine collagen, collagen, porcine recombinant collagen, human collagen, hyaluronic acid and hyaluronic acid derivatives, gelatin matrices and combinations thereof. Each possibility represents a separate embodiment of the present invention.
[0085] According to some embodiments, the biocompatible ceramic material is in the form of granules and/or particles. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the biocompatible ceramic material comprises granules and/or particles having the same/different sizes. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the biocompatible ceramic material is in the form of granules and/or particles of a suitable size for the size of the treated area. Each possibility represents a separate embodiment of the present invention. Under some embodiments, applicators containing large granules of a biocompatible ceramic material are suitable for treating deep and/or large lines, wrinkles or folds.
[0086] According to some embodiments, the biocompatible ceramic material comprises granules and/or particles, having a size of up to 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 µm. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the biocompatible ceramic material comprises granules and/or particles having a size of 25-54µm. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the biocompatible ceramic material comprises granules and/or particles having a size of 10-50μm. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the biocompatible ceramic material comprises granules and/or particles having a size of 5-20µm. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the biocompatible ceramic material comprises granules and/or particles having a size of about 40 µm. Each possibility represents a separate embodiment of the present invention. In some embodiments, the biocompatible ceramic material particles are about 10 to 100 micrometers, preferably about 40 micrometers. Each possibility represents a separate embodiment of the present invention.
[0087] According to some embodiments, the skin improving composition comprises at least 1, 2, 3, 4, 5, 10, 15, 25, 30, 40,50, 60, 70, 80, 90, 95 percent © of biocompatible ceramic material. Each possibility represents a separate embodiment of the present invention. In some embodiments, the skin enhancing composition comprises at least 30% biocompatible ceramic material.
[0088] According to some embodiments, the composition of the invention comprises at least one biodegradable carrier. According to some embodiments, the composition of the invention comprises at least one biocompatible ceramic and at least one biodegradable carrier. According to some embodiments, the composition of the invention comprises at least one biocompatible ceramic, at least one biodegradable carrier, and at least one additional skin-improving material. In some embodiments, the composition of the invention comprises hydroxyapatite and at least one biodegradable carrier. In some embodiments, the composition of the invention comprises hydroxyapatite and polyethylene glycol particles. According to some embodiments, the composition of the invention comprises hydroxyapatite particles, magnesium sulfate and polyethylene glycol.
[0089] According to some embodiments, the biodegradable carrier is selected from the group consisting of: a salt, a biodegradable polymer and a combination thereof. Each possibility represents a separate embodiment of the present invention. In some embodiments, the biodegradable carrier is a salt. In some embodiments, the salt is a water-soluble salt. According to some embodiments, the salt is selected from the group consisting of: sodium sulfate, sodium chloride, magnesium sulfate, magnesium citrate, magnesium chloride and a combination thereof. Each possibility represents a separate embodiment of the present invention.
[0090] According to some embodiments, the biodegradable carrier is a biodegradable polymer. According to some embodiments, the biodegradable polymer is a polymer selected from the group consisting of: Polyethylene Glycol (PEG), Polyglactin 910, Polyglecapron 25, Polydioxanone, Lactomer 9-1, Glycomer 631, Polyglyconate and combinations thereof. Each possibility represents a separate embodiment of the present invention. In some embodiments, the biodegradable carrier comprises magnesium sulfate and/or polyethylene glycol. Each possibility represents a separate embodiment of the present invention. Under some embodiments, PEG as used herein has a molecular weight between 20 and 50 kDa. According to some embodiments, a biodegradable carrier comprising 20-50 kDa PEG has a thick paste consistency. In some embodiments, the biodegradable carrier is Polyglactin 910 and/or magnesium sulfate. Each possibility represents a separate embodiment of the present invention.
According to some embodiments, the biodegradable carrier is degradable within 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12 hours of insertion of the microneedles into the skin of a subject. Each possibility represents a separate embodiment of the present invention. In some embodiments, the biodegradable polymer is degradable within 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12 hours of insertion of the microneedles into the skin of a subject. Each possibility represents a separate embodiment of the present invention. In some embodiments, the biodegradable carrier is degradable within 0.5, 1, 2, 3, 4, 5, 6, 7 days of insertion of the microneedles into the skin of a subject. Each possibility represents a separate embodiment of the present invention. In some embodiments, the biodegradable polymer is degradable within 0.5, 1, 2, 3, 4, 5, 6, 7 days of insertion of the microneedles into the skin of a subject. Each possibility represents a separate embodiment of the present invention. Typically, the biodegradable carrier will biodegrade within less than 7 days of inserting the microneedles into a subject's skin, preferably less than 2 days, more preferably less than 1 day. Each possibility represents a separate embodiment of the present invention. Without wishing to be bound by any theory or mechanism, rapid biodegradation of the biodegradable carrier within hours or days of introduction into a subject's body results in the uniform distribution of the biocompatible ceramic material and/or the skin enhancing material in the treated area, thus achieving the uniform presentation of the defect/deficiency of treated skin. According to some embodiments, after insertion of the composition of the invention into the subject's skin, the biodegradable carrier undergoes biodegradation and the biocompatible ceramic remains within a subject's skin for at least several months, preferably up to a year, more preferably more of one year. Each possibility represents a separate embodiment of the present invention.
[0092] According to some embodiments, the insertion of microneedles comprising the skin-improving composition into the skin of a subject results in biodegradation of rapidly degrading elements in the composition, thus resulting in release of the biocompatible ceramic into the treated area. In some embodiments, the rapidly degrading element is a biodegradable carrier such as, but not limited to, magnesium sulfate and/or polyethylene glycol. Each possibility represents a separate embodiment of the present invention. It should be understood that, according to some modalities, the biodegradation of elements in the composition such as a biodegradable carrier aids in the homogeneous propagation of the biocompatible ceramic in the treated area. According to some modalities, following the biodegradation of fast-degrading elements, such as a biodegradable carrier, the biocompatible ceramic is transferred from the microneedle to the treated area. As used herein, rapidly degrading elements refer to those elements within the composition of the invention that undergo biodegradation within hours or up to 7 days from insertion of the microneedles of the invention into the skin of a subject. It should be understood that a biocompatible ceramic is not a rapidly degrading element of the composition of the invention. In some embodiments, after administering the applicator of the invention for a desired period, the applicator and microneedles are removed from the subject while at least part of the composition remains in the treated area.
[0093] According to some embodiments, the biodegradable carrier is comprises water and/or glycerol and/or carboxymethylcellulose. Each possibility represents a separate embodiment of the present invention. In some embodiments, the biodegradable carrier comprises water, glycerol and carboxymethylcellulose. According to some embodiments, the biodegradable carrier is comprises carboxymethylcellulose.
[0094] According to some embodiments, the composition of the invention comprises a biocompatible ceramic material in the form of granules and/or particles. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the composition of the invention comprises a biocompatible ceramic material in the form of granules and/or particles surrounded by at least one biodegradable carrier. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the composition of the invention comprises a biocompatible ceramic material in the form of granules and/or particles surrounded by at least one biodegradable polymer. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the composition of the invention comprises a biocompatible ceramic material in the form of granules and/or particles surrounded by at least one salt. Each possibility represents a separate embodiment of the present invention. In some embodiments, the composition of the invention comprises hydroxyapatite in the form of granules and/or particles. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the composition of the invention comprises hydroxyapatite in the form of granules and/or particles surrounded by at least one biodegradable carrier. Each possibility represents a separate embodiment of the present invention.
[0095] Without wishing to be limited by any theory or mechanism, granules or particles of a biocompatible ceramic material, such as, but not limited to, hydroxyapatite, surrounded by a biodegradable carrier, may spread homogeneously in the treated area upon degradation of the biodegradable carrier by dissolution, enzymatic activity and the like.
[0096] According to some embodiments, addition of a biodegradable polymer to the composition of the invention results in a composition having a gel, a paste or a similar solid consistency. Each possibility represents a separate embodiment of the present invention. According to some embodiments, a gel, paste or similar solid composition can be easily inserted into the intermediate part of the microneedles of the invention. In some embodiments, the addition of a salt to the composition of the invention aids in the uniform dispersion of the biocompatible ceramic within the composition. Without wishing to be bound by any theory or mechanism, the addition of a salt to the composition of the invention can result in diffusion of water into the composition, thus aiding in the uniform dispersion of the biocompatible ceramic within the composition and/or within the treated area.
In this document, the terms "skin enhancing material" and "filler" refer to agents and compositions useful for ameliorating skin defects. In some embodiments, a skin filler material is a cutaneous and/or subdermal filler. Each possibility represents a separate embodiment of the present invention. Suitable skin enhancing materials according to the invention include, but are not limited to, proteins, polysaccharides, lipids, synthetic polymers and combinations thereof. Each possibility represents a separate embodiment of the present invention. According to some embodiments, a skin enhancing material according to the invention is any material known in the art that is suitable for filling in wrinkles, wrinkles, depressed scars or unwanted lines in a subject's skin. According to some embodiments, a skin enhancing material according to the invention is any skin enhancing material that can be delivered using microneedles. In some embodiments, a biocompatible ceramic material is a skin enhancing material. According to certain embodiments, a skin enhancing material refers to an inert, biocompatible material. "Inert material" in this document refers to a non-antigenic, non-carcinogenic, non-teratogenic, and non-migratory augmentation material.
[0098] Under some modalities, skin enhancing materials include allogeneic products, xenogenic products and synthetically derived products. Each possibility represents a separate embodiment of the present invention.
[0099] According to some embodiments, the skin improving composition of the invention comprises at least one biocompatible ceramic material, at least one biodegradable carrier and at least one type of additional skin improving material. According to some embodiments, the composition of the invention additionally comprises at least one type of skin improving material selected from the group consisting of: a natural biodegradable substance, a biodegradable synthetic polymer, a non-biodegradable synthetic polymer, and combinations thereof . Each possibility represents a separate embodiment of the present invention. According to some embodiments, the composition of the invention further comprises at least one type of skin improving material selected from the group consisting of: a natural biodegradable substance, a biodegradable synthetic polymer, a non-biodegradable synthetic polymer, a natural substance non-biodegradable, and their combinations. Each possibility represents a separate embodiment of the present invention.
[00100] According to some modalities, a natural biodegradable substance is selected, for example, from the group consisting of: bovine collagen, porcine collagen, recombinant collagen, human collagen, gelatin, hyaluronic acid, hyaluronic acid derivative, dermal matrix of dry acellular particles, allogeneic fat and their combinations. Each possibility represents a separate embodiment of the present invention.
[00101] According to some embodiments, a synthetic biodegradable polymer is selected, for example, from the group consisting of: poly-L-lactic acid, polyethylene oxide, Carboxymethylcellulose and their combinations. Each possibility represents a separate embodiment of the present invention.
[00102] According to some embodiments, a non-biodegradable synthetic polymer is selected, for example, from the group consisting of: polymethyl methacrylate (PMMA), polymethyl methacrylate granules, silicones, silicone rubbers, expanded polytetrafluoroethylene, polyacrylamide, polyalkylimide and combinations thereof. Each possibility represents a separate embodiment of the present invention.
[00103] According to some embodiments, the skin improving composition of the invention comprises a combination of materials comprising at least one biocompatible ceramic material, and at least one type of additional skin improving material. According to some embodiments, the skin improving composition of the invention comprises at least one combination of materials comprising at least one biocompatible ceramic material, and at least one type of skin improving material other than the biocompatible ceramic material. According to some embodiments, the skin improving composition comprises at least one biocompatible ceramic material, a biodegradable carrier, and at least one type of skin improving material selected from the group consisting of: a natural biodegradable substance, a polymer biodegradable synthetic, a non-biodegradable synthetic polymer, and combinations thereof. Each possibility represents a separate embodiment of the present invention.
[00104] According to some embodiments, the skin enhancing composition comprises hydroxyapatite particles. In some embodiments, the skin improving composition comprises hydroxyapatite and at least one type of skin improving material other than hydroxyapatite. According to some embodiments, the skin enhancing composition comprises hydroxyapatite and at least one type of soft tissue enhancing material selected from the group consisting of: a natural biodegradable substance, a biodegradable synthetic polymer, a non-biodegradable synthetic polymer , a natural non-biodegradable substance, and combinations thereof. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the skin enhancing composition comprises hydroxyapatite and at least one type of soft tissue enhancing material selected from the group consisting of: a natural biodegradable substance, a biodegradable synthetic polymer, a non-biodegradable synthetic polymer , a non-biodegradable synthetic polymer, and combinations thereof. Each possibility represents a separate embodiment of the present invention.
[00105] According to some embodiments, the composition of the invention comprises less than 50% by weight of water-soluble skin improving materials, such as, but not limited to, collagen, hyaluronic acid and gelatin. Each possibility represents a separate embodiment of the present invention.
[00106] Preferably, skin enhancing materials that can be comprised in the composition of the invention are effective dermal fillers approved by the US Food and Drug administration, including but not limited to fillers comprising structural proteins, polysaccharides or synthetic polymers. Exemplary modalities of skin enhancing materials that can be used include collagen, such as reconstituted bovine collagen products, including, but not limited to, ZYDERM I®, ZYDERM II®, and ZYPLAST® (Collagen Corporation); COSMODERM ™ and COSMOPLAST ™ natural human collagen (INAMED); and the subject's endogenous collagen, AUTOLOGEN ®, produced by Collagenesis. Additional examples of dermal fillers can be selected from those comprising hyaluronic acid, including but not limited to, products such as HYLAFORM ® gel, manufactured by INAMED and Genzyme Corporations, derived from poultry gall crest; and RESTYLANE ® manufactured by Medieis, a hyaluronic acid derivative derived from streptococcal bacterial fermentation. Hyaluronic acid according to the present invention includes both cross-linked and/or non-cross-linked hyaluronic acid derivatives as are known in the art. Each possibility represents a separate embodiment of the present invention. According to some embodiments, collagen according to the invention is selected from the group consisting of: allogeneic collagen, xenogenic collagen and a combination thereof. Each possibility represents a separate embodiment of the present invention. According to other embodiments, a skin enhancing material is human cadaveric dermis cultured from a cadaver, such as, but not limited to, materials having the brand names Cymetra, Dermalogen, Alloderm and Fascian.
[00107] According to some embodiments, the applicator of the invention comprises a biologically active agent. According to some embodiments, the composition of the invention comprises a biologically active agent. According to some modalities, the biologically active agent is selected from a group consisting of: an enzyme, a drug, a toxin and a combination thereof. Each possibility represents a separate embodiment of the present invention.
[00108] According to some modalities, the drug is an analgesic. According to some embodiments, when the applicator of the invention is used to deliver the skin improving composition subcutaneously, at least one analgesic is provided by the applicator of the invention along with the skin improving composition. In accordance with some embodiments, the skin enhancing composition of the invention additionally comprises an analgesic. According to some embodiments, the methods of the invention further comprise administering an analgesic. According to some embodiments, every analgesic known in the art can be used with the present invention, such as, but not limited to: lidocaine, paracetamol, non-steroidal anti-inflammatory drug (NSAID), COX-2 inhibitor, opiates or morphinomimetics . Each possibility represents a separate embodiment of the present invention. In some embodiments, an analgesic that can be used with the present invention is lidocaine.
[00109] According to some modalities, the drug is a drug known in the art to assist in filling lines, wrinkles, unwanted folds and the like. According to some embodiments, examples of drugs that may be comprised in the composition of the invention include, but are not limited to, anti-psoriasis drugs, muscle relaxants, and a combination thereof. Each possibility represents a separate embodiment of the present invention.
[00110] According to some modalities, the drug is a drug for the treatment of pathological scars. According to some modalities, the medicine for the treatment of pathological scars is a corticosteroid. In some embodiments, the corticosteroid is any corticosteroid known in the art for treating pathological scars, such as, but not limited to, triamcinolone.
[00111] According to some embodiments, the toxin is botulinum toxin. According to some embodiments, the composition of the invention comprises botulinum toxin. According to some embodiments, the applicator of the invention comprises botulinum toxin.
[00112] According to some embodiments, the skin improving composition of the invention additionally comprises a medical pigment. According to some embodiments, the microneedles of the invention comprise a medical pigment. As used herein, the term "medical pigment" refers to a colored material suitable for insertion into the skin of a subject. Under some modalities, medical pigments have regulatory approval for insertion into a subject's skin. According to some embodiments, medical pigments are pigments known in the art to be suitable for micro-pigmentation treatments. In non-limiting examples, medical pigments suitable for use in accordance with the present invention include, but are limited to, pigments such as BIOCHROMADERM® (Biotic Phocea) or Signature Series (Micro-PigmentationCentre, Inc.). Possible medical pigments for use with the applicator of the present invention may be pigments for scar camouflage, areola reconstruction or lip reshaping.
[00113] According to some embodiments, a microneedle comprising a medical pigment is suitable for micro-pigmentation treatments. According to some modality, micro-pigmentation treatments are selected from the group consisting of: concealment of scars, concealment and/or blurring of skin pigmentation, nipple areola construction and/or improvement, freckle correction, coloration lip, eyebrow, coloring and a combination of these. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the microneedles of the invention comprise a composition comprising a medical pigment. According to some embodiments, the applicator of the invention comprises microneedles comprising a medical pigment without a biocompatible ceramic or skin-improving composition. Each possibility represents a separate embodiment of the present invention.
[00114] According to some embodiments, the present invention provides an applicator configured for administering a medical pigment to a subject's skin, the applicator comprising a substrate and an array of microneedles; wherein the substrate has a generally flat structure having two opposing surfaces, with one surface intended to be placed proximally on a subject's skin and the other surface facing away from the subject's skin; wherein the array of microneedles is located on the proximal surface of the subject's skin, the array comprising a plurality of microneedles, wherein each of the microneedles comprises a composition comprising at least one medical pigment. In some embodiments, the applicator is configured to deliver a medical pigment to a subject's skin and/or a subject's subcutaneous layers. Each possibility represents a separate embodiment of the present invention.
[00115] According to some embodiments, microneedles comprise a skeleton made of a rigid material, the skeleton consisting of: a sharp-tipped section, located at one end of the skeleton configured to penetrate a subject's skin, a base over an opposite end of the skeleton and an intermediate section connecting the spun end section and the base; and a composition comprising a medical pigment, wherein the composition surrounds at least part of the intermediate section, such that a diameter of the sharpened section is greater than the diameter of the composition.
According to some embodiments, the present invention provides a method for carrying out the treatment of a micro-pigment to a subject, the method comprises administering to the subject an applicator configured for administering a medical pigment to a subject's skin. , the applicator comprising a substrate and an array of microneedles; wherein the substrate has a generally flat structure having two opposing surfaces, with one surface intended to be placed proximally on a subject's skin and the other surface facing away from the subject's skin; wherein the array of microneedles is located on the proximal surface of the subject's skin, the array comprising a plurality of microneedles, wherein each of the microneedles comprises a composition comprising at least one medical pigment.
[00117] According to some embodiments, the applicator of the invention comprises microneedles. According to other embodiments, the applicator of the invention comprises an array of microneedles. According to other embodiments, the applicator of the invention comprises at least one array of microneedles. An array of microneedles may include a mixture of microneedles, having, for example, various lengths, diameters, cross-sectional shapes and spacing between the microneedles. Each possibility represents a separate embodiment of the present invention. In some embodiments, the length of the microneedles of the invention is typically between about 0.05 and 1 mm, preferably between 10 microns and 500 microns, and more preferably between 30 and 200 microns. Each possibility represents a separate embodiment of the present invention. The length of the microneedles can be selected according to the specific application or the treated tissue. Each possibility represents a separate embodiment of the present invention. For certain applications, it may be desirable to use slightly larger microneedles. Thus, according to some embodiments, the length of the microneedles of the invention is above 1 mm. According to further embodiments the length of the microneedles of the invention is up to 2 mm.
[00118] According to some embodiments, microneedles larger than 1 mm can be used to deliver the skin enhancing composition subcutaneously. Under some modalities, microneedles can be used to deliver the skin enhancing composition to areas with deep wrinkles and/or skin deficiency. Each possibility represents a separate embodiment of the present invention. Under some modalities, microneedles no larger than 1mm can be used to deliver the skin enhancing composition to areas with deep wrinkles and/or deficient skin and/or subcutis. Each possibility represents a separate embodiment of the present invention.
[00119] According to some embodiments, the applicator of the invention comprises microneedles having various lengths. According to some embodiments, the applicator of the invention comprises microneedles of varying lengths and/or varying degrees of thickness. Each possibility represents a separate embodiment of the present invention. In accordance with some embodiments, the applicator of the invention comprises microneedles of varying lengths and/or varying degrees of thickness in correlation with the location of the microneedles in the substrate. Each possibility represents a separate embodiment of the present invention. In accordance with some embodiments, the applicator of the invention comprises microneedles having variable lengths in correlation to the location at which they are configured to lie within the area to be treated. Each possibility represents a separate embodiment of the present invention.
[00120] According to some embodiments, microneedles configured to lie at a deeper point of a line, wrinkle or fold to be treated are longer than microneedles configured to lie at a superficial point of the line, wrinkle or fold to be treated. In a non-limiting example, microneedles configured to lie close to the edges of a line, wrinkle or fold to be treated are shorter than microneedles configured to lie in the center of the line, wrinkle or fold to be treated. According to some modalities, microneedles located in the center of the microneedle array are longer than microneedles located near the margins of the microneedle array. An applicator comprising microneedles having variable lengths may be able to more precisely and evenly fill a line, wrinkle or crease.
[00121] According to some embodiments, the applicator of the invention comprises microneedles having varying degrees of thickness in correlation with the location in which they are configured to lie within the area to be treated. According to some modalities, microneedles configured to lie at a deeper point of a line, wrinkle or fold to be treated are thicker than microneedles configured to lie at a superficial point in the line, wrinkle or fold to be treated .
[00122] FIG. 1a schematically illustrates a top view of applicator 100 according to some exemplary embodiments. According to the modalities shown in FIG. 1, the applicator (100) includes a substrate (102) shown here in the form of a rectangular patch, but can be any other shape, such as, but not limited to, a square, a circle, a strip, or any other shape. Substrate (102) is preferably made of a flexible material, such as, but not limited to, medical plastic, rubber or latex and is preferably configured to conform to the curvature of the skin surface. Substrate (102) includes two surfaces: an inner surface (104) and an outer surface (106). The inner surface (104) is configured to be placed proximal to the skin (e.g., to adhere to the skin). The inner surface (104) includes the microneedle array (108).
[00123] FIG. 2A schematically illustrates a top view of applicator 200 in accordance with some exemplary embodiments. According to the modalities shown in FIG. 2A, the applicator (200) includes a substrate (202) shown here in the form of a strip composed of several segments (204, 206, w 208), but can be any other shape, such as, but not limited to, a rectangle, a square, circle, or any other shape. The substrate (202) is preferably made of a flexible material such as, but not limited to, medical plastic, rubber or latex and is preferably configured to conform to the curvature of the skin surface. The segments (204, 206 and 208) preferably are configured to flexibly move with respect to each other. The Substrate (202) includes two surfaces: an inner surface (210) and an outer surface (212). The inner surface (210) is configured to be placed proximal to the skin (e.g., to adhere to the skin). The inner surface (210) includes the microneedle array (214).
[00124] FIG. 3 schematically illustrates a top view of the applicator (300) in accordance with some exemplary embodiments, showing the surface (304) of the substrate (302). Surface (304) is intended to be placed proximally to the skin of a subject, while surface (306) is intended to face away from the subject. The surface (304) comprises the microneedle array (308). The microneedle array (308) comprises five rows of microneedles (310a, 310b, 310c, 310d, 310e), the microneedles being attached or integrally formed on the surface (304). Each possibility represents a separate embodiment of the present invention. Microneedles in the microneedle row (310c) located in the center of the array (308) are thicker than microneedles (310b and 310d), which are in turn thicker than microneedles (310a and 310e), located closer to the ends /arrangement margins (308). Under some embodiments, thick microneedles are configured to deliver a greater amount of skin enhancing composition than thin microneedles. Under some embodiments, thick microneedles are configured to deliver a large amount of skin-enhancing composition to the central/deep region of a wrinkle, line or the like to be treated, requiring greater improvement than the edges and/or margins of the skin. a wrinkle, line or the like. In accordance with other embodiments, fine microneedles are configured to deliver a low amount of skin enhancing composition to the edges and/or edges of a wrinkle, line or the like.
[00125] According to the modalities shown in FIG. 3, except for the portion comprising the microneedle array (308), the substrate (302) is substantially transparent. The substrate (302) comprises markings (312a, 312b, 312c, 312d, 312e312f) indicating the location of the microneedle array (308) on the surface (304). In some embodiments, the markings (312a, 312b, 312c, 312d, 312e, 312f) aid in placing the applicator (300) on a subject's skin. According to some embodiments, the markings (312a, 312b, 312c, 312d, 312e, 312f) are on the surface (304) and/or on the surface (306). Each possibility represents a separate embodiment of the present invention.
[00126] As used herein, the term "microneedles" refers to protruding structures designed to pierce the skin and facilitate the delivery of various types of compounds. In some embodiments, microneedles facilitate delivery of the composition of the invention to dermal and/or subdermal compartments of the skin. Each possibility represents a separate embodiment of the present invention. According to some embodiments, subcutaneous delivery of a skin enhancing composition can be achieved by the applicator of the invention if the microneedles comprised in the applicator are longer than the thickness of the skin to be treated. According to some embodiments, the length of the microneedles comprised in the applicator of the invention is configured to allow dermal and/or subcutaneous delivery of a skin improving composition. Each possibility represents a separate embodiment of the present invention.
[00127] According to some embodiments, the length of the microneedles comprised in the applicator of the invention is configured to allow the delivery of a skin improvement composition to the dermis and/or lower layers of the skin. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the microneedles comprised in the applicator of the invention are configured to allow delivery of a skin improving composition to the dermis and/or lower layers of the skin without delivering the skin improving composition to the epidermis layer of the skin. . Each possibility represents a separate embodiment of the present invention. According to some embodiments, the length of the microneedles comprised in the applicator of the invention is configured so as not to allow delivery of a skin improving composition to the epidermis. In some embodiments, the base length of the microneedles is configured to not allow delivery of a skin enhancing composition to the epidermal layer of the skin. Under some embodiments, long microneedles allow delivery of the skin enhancing composition to deep and/or subcutaneous layers of the skin, such as, but not limited to, the hypodermis. Each possibility represents a separate embodiment of the present invention.
[00128] According to some embodiments, each microneedle according to the invention comprises the skin improvement composition and a skeleton made of a rigid material. According to some modalities, the rigid material is selected from the group consisting of: metal, plastic, a ceramic material, silicone and a combination thereof. Each possibility represents a separate embodiment of the present invention. According to some modalities, the rigid material is biocompatible. According to some embodiments, the rigid material is biodegradable. In some embodiments, the rigid material is rigid to allow the microneedles to be inserted into the subject's skin. In some embodiments, the rigid material is a metal. According to some embodiments, each microneedle according to the invention comprises the skin-improving composition and a skeleton made of metal. According to some modalities, the metal is selected from the group consisting of: stainless steel, titanium, iron, gold, silver, platinum and a combination and/or alloy thereof. Each possibility represents a separate embodiment of the present invention. Under some embodiments, the rigid material is preferably a material approved by the Food and Drug Association (FDA) for implantation and/or parenteral administration. Each possibility represents a separate embodiment of the present invention.
[00129] According to some modalities, the skeleton of the microneedles is removed from the subject by removing the applicator from the subject. In some embodiments, after removing the applicator of the invention from the subject's skin, the microneedle skeletons are removed while at least part of the composition of the invention remains within the subject's skin or subcutaneous region of skin. Each possibility represents a separate embodiment of the present invention. According to some embodiments, after removing the applicator of the invention from the subject's skin, at least part of the biocompatible ceramic remains within the subject's skin or subcutaneous region of skin, while the microneedle skeletons are removed. Each possibility represents a separate embodiment of the present invention.
[00130] According to some embodiments, the skeleton of each microneedle comprises a sharp point section, a base and an intermediate section, connecting the sharp point section and the base. As used here, the terms "sharp section", "sharp section" and "point" are used interchangeably. According to some modalities, the end section, the base section and the middle section of the skeleton are integrally formed. According to some embodiments, the nose section, the base and the middle section of the skeleton are made of a single piece of material. According to some modalities, the end section, the base section and the middle section of the skeleton are attached to each other.
[00131] According to some embodiments, the sharp-tipped section of the microneedle skeleton is the most proximal part of the microneedle. As used herein, the proximal side of the microneedle refers to the side of the microneedle that is closest to the subject and farthest from the applicator substrate. The base portion and sharp end section of the microneedle skeleton are at opposite ends of the microneedle skeleton. As used herein, microneedle base refers to the side of the microneedle that is furthest from the subject and closest to the surface of the substrate intended to be placed proximally to a subject's skin. In some embodiments, the base of the microneedle skeleton is the microneedle base.
[00132] According to some embodiments, the sharp-tipped section of the microneedle skeleton is configured to penetrate a subject's skin. Under some modalities, the sharp-edged section is of any shape, which allows it to penetrate a subject's skin. According to some modalities, the sharp point section has a shape selected from the group consisting of: a cone, a pyramid, a triangular pyramid and a polygonal pyramid. Each possibility represents a separate embodiment of the present invention. According to some modalities, the sharp point section is attached to the middle section of the microneedle skeleton. In some embodiments, the sharp point section is integrally formed with the middle section of the microneedle skeleton.
[00133] According to some embodiments, the diameter of the sharp point section is larger than the diameter of the skin enhancing composition. According to some embodiments, the diameter of the sharp point section is larger than the diameter of the middle part of the microneedle.
[00134] According to some embodiments, the largest diameter of the sharp point section is larger than the largest diameter of the skin enhancing composition. According to some embodiments, the largest diameter of the sharp point section is larger than the largest diameter of the middle part of the microneedle. As used herein, sharp point section diameter refers to the greatest distance that can be formed between two opposing parallel lines tangent to the boundary of a cross section through the sharp point section, where the cross section is parallel to the substrate. According to some embodiments, the middle part of the microneedle comprises the middle part of the microneedle skeleton and the enhancement composition. According to some embodiments, the middle part of the microneedle comprises the middle part of the microneedle skeleton and the enhancement composition.
[00135] According to some embodiments, the sharp point section pierces the subject's skin allowing the insertion of skin enhancing composition. Under some embodiments, a sharp-edged section having a diameter greater than the diameter of the skin enhancing composition allows the formation of a skin piercing large enough for the skin enhancing composition to enter the skin without spillage. of the composition outside the body or inside the epidermis. Each possibility represents a separate embodiment of the present invention.
[00136] According to some embodiments, the base of the microneedles does not comprise the skin improving composition. According to some modalities, the base of the skeleton has a shape selected from the group consisting of: a cylinder, a rectangular box, a cuboid, a triangular box and a polygonal box. Each possibility represents a separate embodiment of the present invention. In some embodiments, the base of the skeleton is configured to provide stability to the microneedle. In some embodiments, the base of the microneedles is configured to prevent delivery of a skin enhancing composition to the epidermal layer of the skin.
[00137] According to some arrangements, the base of the microneedle is attached to the substrate. In some embodiments, the base of the microneedle is attached to the surface of the substrate intended to be placed proximally to a subject's skin. In some embodiments, the base of the microneedle is formed integrally with the substrate. In some embodiments, the base of the microneedle is formed integrally with the surface of the substrate to be placed proximally to a subject's skin. In some embodiments, the microneedle base and substrate are made from a unitary piece of material. In some embodiments, the microneedle base and substrate surface intended to be placed proximally to a subject's skin are made from a unitary piece of material.
[00138] According to some modalities, the length of the base is equal to or greater than the thickness of the epidermis in a treated area. Each possibility represents a separate embodiment of the present invention. In some embodiments, a base having a length equal to or greater than the thickness of the epidermis in the treated area prevents delivery of the skin enhancing composition to the epidermis. Preventing delivery of a skin-enhancing composition to the epidermis can prevent material waste, enhance the composition-enhancing effect, or prevent inflammation and/or infection of the treated site. Each possibility represents a separate embodiment of the present invention.
[00139] According to some modalities, the length of the base is equal to or greater than the combined thickness of the epidermis and the dermis in a treated area. In accordance with some embodiments, microneedles having a base at least as long as the combined thickness of the epidermis and dermis of the treated area are configured to prevent delivery of the skin enhancing composition to the dermis and epidermis. Under some embodiments, microneedles having a base at least as long as the combined thickness of the epidermis and dermis of the treated area are configured to deliver the skin enhancing composition subcutaneously. Without wishing to be limited by the mechanism, varying the length of the base may determine the subcutaneous layer and/or skin into which the composition is delivered.
[00140] According to some embodiments, all microneedles in the same applicator have the same base length. According to some embodiments, the applicator of the invention comprises microneedles having varying base lengths. According to some embodiments, the length of said base is variable in correlation with the location where each microneedle is configured to be located in a treated area. According to some embodiments, the applicator of the invention comprises microneedles of varying base lengths in correlation with the location of the microneedles on the substrate. In accordance with some embodiments, the applicator of the invention comprises microneedles having varying base lengths in correlation to the thickness of the epidermis and/or dermis at the location each microneedle is configured to be positioned. Each possibility represents a separate embodiment of the present invention. In accordance with some embodiments, the applicator of the invention comprises microneedles having variable lengths in correlation to the location at which they are configured to lie within the area to be treated.
[00141] According to some embodiments, microneedles configured to be placed in a treatment area, having a thick epidermis have a longer base than microneedles configured to be placed in a treatment area, having a thin epidermis. It should be noted that, according to some embodiments, an applicator configured to be placed in a treated area having an epidermis and/or dermis with varying levels of thickness may comprise microneedles having bases of different lengths corresponding to different levels of thickness. Each possibility represents a separate embodiment of the present invention.
[00142] According to some embodiments, microneedles located in the center of a microneedle array comprise a longer base than microneedles located near the edges of the microneedle array. In accordance with some embodiments, microneedles configured to lie near the edges of a line, crease or fold to be treated comprise a shorter base than microneedles configured to lie in the center of the line, crease or fold to be treated. In accordance with some embodiments, a microneedle having a long base is configured to deliver the skin enhancing composition to a deeper or subcutaneous layer of skin than a microneedle having a short base. Each possibility represents a separate embodiment of the present invention.
[00143] According to some embodiments, a diameter of the base is smaller than the diameter of the sharp point section. Under some arrangements, the largest diameter of the base is smaller than the largest diameter of the sharp point section. In some embodiments, the diameter of the base is equal to the diameter of the skin enhancing composition. According to some embodiments, the diameter of the base is equal to the diameter of the middle part of the microneedle. As used herein, base diameter refers to the greatest distance that can be formed between two opposing parallel lines tangent to the boundary of a cross section through the base of the microneedle, where the cross section is parallel to the substrate.
[00144] According to some embodiments, the middle section of the microneedle skeleton is the part of the skeleton connecting between the sharp point section and the base of the skeleton. In some embodiments, the skin enhancing composition, at least in part, surrounds the midsection of the microneedle skeleton. In some embodiments, the middle part of the microneedle is the part of the microneedle comprised between the sharp point section of the microneedle skeleton and the base of the microneedle skeleton. According to some embodiments, the middle part of the microneedle comprises the middle part of the microneedle skeleton and the enhancement composition.
[00145] According to some embodiments, the mid-section of the microneedle skeleton may be in any suitable shape to provide the microneedle with rigidity and provide support for the skin-enhancing composition. In some embodiments, the midsection of the skeleton is in the form of a longitudinal core extending substantially from the center of the sharp-edged section to the center of the base. In some embodiments, the middle section of the skeleton comprises a longitudinal core substantially extending from the center of the sharp point section to the center of the base. As used herein, the term "longitudinal core" refers to a longitudinal piece of a rigid, non-biodegradable, compatible material extending substantially through the center of the intermediate portion of the microneedle. According to some embodiments, the longitudinal core can be of any shape, such as, but not limited to, a cone, a cylinder, a pyramid, a rectangular box, a triangular box, a polygonal box and the like. According to some embodiments, the longitudinal core has the same dimensions over the entire length of the middle part of the microneedle. In some embodiments, the middle section of the skeleton is integrally formed with the sharp end section. In some embodiments, the middle section of the skeleton is integrally formed with the leak restrictor. According to some embodiments, the middle section of the skeleton extends through the base part and is at least partially inserted into the substrate. In some embodiments, the middle section of the skeleton extends through the base part and is at least partially inserted into the substrate perpendicularly. Without wishing to be limited by any mechanism, the intermediate section of a skeleton in the form of a longitudinal core inserted through the base of the skeleton and into the substrate in the form of a cross gives substantial stability to the microneedle. According to some modalities, the intermediate section is integrally formed with the base of the microneedle skeleton. As used herein, the terms "extension", "skeletal extension", "middle section extension", "middle section extension" and "microneedle extension" are used interchangeably and relate to a middle section extension. microneedle skeleton through the base of the skeleton and at least partially into the applicator substrate.
[00146] According to some embodiments, the skin enhancing composition, at least in part, surrounds the middle part of the microneedle skeleton. In some embodiments, the skin enhancing composition at least partially surrounds the longitudinal core. In some embodiments, the skin enhancing composition involves the longitudinal core. Under some embodiments, the skin enhancing composition surrounding the midsection of the skeleton can form any shape, such as, but not limited to: a cylinder, a rectangular box, a triangular box, a polygonal box, and the like.
[00147] As used herein, the diameter of the skin enhancement composition refers to the greatest distance that can be formed between two opposite parallel lines tangent to the boundary of a cross section through the middle part of the microneedle, where the cross section is parallel to the substrate. According to some embodiments, the diameter of the skin enhancing composition refers to the greatest distance that can be formed between two opposing parallel lines tangent to a cross-sectional boundary across the skin enhancing composition. According to some embodiments, the diameter of the skin enhancement composition refers to the greatest distance that can be formed between two opposite parallel lines tangent to the boundary of a cross section through the skin enhancement composition and the intermediate section of the skeleton of the microneedle.
[00148] According to some embodiments, the microneedle skeleton additionally comprises a leak restrictor. According to some embodiments, the leak restrictor is situated between the sharp point section and the middle section of the microneedle skeleton. According to some embodiments, the leak restrictor is integrally formed with the mid-skeletal section and/or the sharp point section. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the leak restrictor is integrally formed with the sharp point section. According to some arrangements, the leak restrictor is attached to the sharp point section.
[00149] According to some embodiments, the leak restrictor is configured to prevent leakage of the skin enhancing composition after extraction of the microneedle from the subject's skin. In some embodiments, the pour restrictor facilitates the sliding of the enhancement composition onto the treated tissue after microneedle extraction from the subject's skin. In some embodiments, the leak restrictor prevents the propulsion of the subject's skin enhancing composition after extraction of the microneedles from the subject's skin. In some embodiments, the skin enhancing composition at least partially surrounds the pour restrictor. In some embodiments, the skin enhancing composition at least partially surrounds the midsection of the composition and at least partially surrounds the pour restrictor.
[00150] According to some modalities, the leak restrictor is in a format selected from the group consisting of: a cone, a pyramid, a triangular pyramid and a polygonal pyramid. Each possibility represents a separate embodiment of the present invention. According to some modalities, the leakage restrictor is in a shape selected from the group consisting of: a cone, a pyramid, a triangular pyramid and a polygonal pyramid; wherein the base of the cone, pyramid, triangular pyramid, or polygonal pyramid is attached or integrally formed with the sharp-tipped section of the microneedle skeleton. Each possibility represents a separate embodiment of the present invention. In some embodiments, the skin enhancing composition slides against the leak restrictor into the treated area concurrently with microneedle extraction from the subject's skin. In a non-limiting example, the leak restrictor is in the form of a cone, where the enhancement composition slides against the cone and onto the treated skin by extracting the microneedles from the skin. In some embodiments, the extraction of microneedles from the skin results from pulling the applicator away from the subject's skin.
[00151] FIG. 1B shows a cross section along line A-A of an applicator (100) of FIG. 1A, in accordance with some embodiments of the invention. The substrate (102) of the applicator (100) comprises microneedles (, 110a, 110b, 110c and 110d). In accordance with some embodiments, the microneedles (110a, 110b, 110c and 110d) are configured to deliver a composition in accordance with embodiments of the invention to unwanted lines, wrinkles, scars, or unwanted folds of a subject's face. According to the embodiment shown in FIG. 1B, the microneedles (110a, 110b, 110c and 110d) in the substrate (102) are substantially the same length. According to other embodiments, the microneedles (110a and 110d) located near the edges of the substrate (102) may have the same length while the microneedles (110b and 110c) located in the center of the substrate (102) may have the same length and be longer than microneedles (110a and 110d). The microneedles (110a) include a skeleton comprising three sections: a sharp-tipped section (112a) configured to penetrate a subject's skin, a base (114a) located at the opposite end of the skeleton, and an intermediate section (116a) for connecting a base (114a) and sharp point section (112a). The base (114a), sharp point section (112a) and the intermediate section (116a) are connected to each other and/or integrally formed with each other. Each possibility represents a separate embodiment of the present invention. The bases (114a, 114b, 114c and 114d) of the microneedles (110a, 110b, 110c and 110d) are in the shape of a cylinder, but may have other shapes, such as, but not limited to, a rectangular box, a cuboid, a triangular box, a polygonal box and the like. The base (114a) is attached to or integrally formed with the substrate (102a). Each possibility represents a separate embodiment of the present invention. The microneedle skeleton (110a) further comprises the pour restrictor (118a) in the form of a cone, situated between the sharp point section (112a) and the intermediate section (116a).
[00152] It should be noted that leakage restrictors (118a, 118b, 118c and 118d) of microneedles (110a, 110b, 110c and 110d) are not limited to the shape of a cone and may have shapes such as, but not limited to , a cone, a pyramid, a triangular pyramid, a polygonal pyramid and the like. The pour restrictor (118a) is formed integrally with the sharp point section (112a) such that the base of the cone forming the pour restrictor (118a) is formed integrally with the base of the cone forming the sharp point section (112a). The intermediate section (116a) is in the form of a longitudinal core extending substantially from the center of the sharp point section (112a) to the center of the base (114a). The microneedle (110a) further comprises the skin enhancing composition (122) surrounding the intermediate section (116). The skin enhancing composition (122) together with the middle section (116) constitutes the middle part of the microneedle (110a). The Leak Restrictor (118a) is configured to prevent leakage of skin enhancing composition (122) after extraction of the microneedle (110a) from a subject's skin.
[00153] It should be understood that bases (114b, 114c, 114d), sharp point sections (112b, 112c, 112d), intermediate sections (116b, 116c, 116d), leak restrictors (118b, 118c, 118d) and Augmenting compositions (122b, 122c, 122d) of microneedles (110b, 110c, 110d), respectively, and the substrate (102) are related to each other essentially as described for the corresponding microneedle elements (110a).
[00154] The intermediate section (116a) sends the extension (120a) through the base (114a) and into the substrate (102). The middle part (116a) and the extension (120a) are perpendicular to the base (114a) and the substrate (102). According to some embodiments, the perpendicular insertion of the intermediate section (116) and the extension (120a) in the base (114a) and the substrate (102), respectively, gives stability to the microneedle (110a). According to the embodiment shown in FIG. 1B, the microneedle extension (120d) (110d) is thicker than the microneedle extensions (120b and 120c) (110b and 110c) which are in turn thicker than the microneedle extension (120a) (110a). According to some embodiments, different microneedles within the same applicator comprise extensions having different thickness levels. According to some embodiments, a microneedle comprising a thick extension is more stable than a microneedle than a thin extension. As used herein, a stable microneedle refers to a microneedle solidly attached to and/or integrally formed with the substrate.
[00155] FIG. 2B shows a cross section along line B-B of the applicator 200 of FIG. 2, according to some embodiments of the invention. The substrate (202) comprises microneedles (216a, 216b, 216c, 216d, 216e). In accordance with some embodiments, microneedles (216a, 216b, 216c, 216d, 216e) are configured to deliver the skin enhancing composition (230a, 230b, 230c, 230d, 230e) to unwanted lines, wrinkles, depressed scars or creases in the the guy's face, one. According to some modalities, microneedles (216a and 216e) are shorter than microneedles (216b and 216d), which are in turn smaller than microneedles (216c). According to some embodiments, microneedles (216a and 216e) are configured to deliver the enhancement composition (230a and 230e) at the ends and/or edges of a wrinkle, line or the like to be treated, the microneedle (216c) is configured to deliver the enhancement composition (230c) to the center/bottom region of a wrinkle, line, or the like to be treated. Each possibility represents a separate embodiment of the present invention. Under some embodiments, applicators configured to be applied to areas with thinner skin (such as, but not limited to, near the eyes) comprise shorter microneedles than applicators configured to be applied to areas with thicker skin (such as such as, but not limited to, nasolabial folds).
[00156] According to some embodiments, microneedles (216a) include a skeleton comprising three sections: a sharp-tipped section (220a) configured to penetrate a subject's skin, a base (222a) located at the opposite end of the skeleton, and an intermediate section (224a) of base connection (222a) and sharp point section (220a). The base (222a), sharp point section (220a) and the intermediate section (224a) are connected to each other and/or integrally formed with each other. Each possibility represents a separate embodiment of the present invention. The bases (222a, 222b, 222c, 222d and 222e) of the microneedles (216a, 216b, 216c, 216d, 216e) are in the shape of a cylinder, but may have other shapes, such as, but not limited to, a rectangular box , a cuboid, a triangular box, a polygonal box and the like. The base (222a) is attached to or integrally formed with the substrate (202a). Each possibility represents a separate embodiment of the present invention. The skeleton of each of the microneedles (216a) further comprises the pour restrictor (226a) in the form of a cone, situated between the sharp point section (220a) and the intermediate section (224a). It should be noted that leakage restrictors (226a, 226b, 226c, 226d,226d) of microneedles (216a, 216b, 216c, 216d, 216e) are not limited to the shape of a cone and may have shapes such as, but not limited to a, a cone, a pyramid, a triangular pyramid, a polygonal pyramid and the like. The pour restrictor (226a) is formed integrally with the sharp point section (220a) such that the base of the cone forming the leak restrictor (226a) is formed integrally with the base of the cone forming the sharp point section (220a). The intermediate section (224a) is in the form of a longitudinal core extending substantially from the center of the sharp point section (220a) to the center of the base (222a). The microneedle (216a) further comprises the skin enhancing composition (230a) surrounding the midsection (224a). The skin improving composition (230a) together with the midsection (224a) constitutes the middle part of the microneedle (216a). The Leak Restrictor (226a) is configured to prevent leakage of skin enhancement composition (230a) after extraction of the microneedle (216a) from a subject's skin. The intermediate section (224a) sends the extension (228a) through the base (222a) and into the substrate (202). The middle part (224a) and the extension (228a) are perpendicular to the base (222a) and the substrate (202). According to some embodiments, the perpendicular insertion of the intermediate section (224) and the extension (228a) in the base (222a) and the substrate (202), respectively, gives stability to the microneedle (216a).
[00157] It should be understood that the bases (222b, 222c, 222d, 222e), the sharp edge sections (220b, 220c, 220d, 220e), the intermediate sections (224b, 224c, 224d, 224e), restrictors of casting (226b, 226c, 226d, 226e), extensions (228b, 228c, 228d, 228e) and augmenting compositions (230b, 230c, 230d, 230e) of microneedles (216b, 216c, 216d216e), respectively, and the substrate ( 202) relate to each other essentially as described for the corresponding microneedle elements (216a).
[00158] The base (222c) of the microneedle (216c) is longer than the bases (222b and 222d) of microneedles (216b and 216d), which are in turn longer than the bases (222a and 222e) of microneedles ( 216a and 216e). According to some embodiments, the applicator of the invention comprises microneedles having bases of varying lengths. Under some embodiments, long microneedle bases, such as the base (222 ) of the microneedle (216c), ensure delivery of augmentation compositions such as (230c) to deep layers of the skin or subcutaneously, without delivery to shallower layers of skin. Each possibility represents a separate embodiment of the present invention.
[00159] FIG. 4a schematically shows the microneedle (400a) on the substrate (401a), in accordance with some embodiments of the invention. In accordance with some embodiments, microneedles (400a) include a skeleton comprising three sections: a sharp-tipped section (402a) configured to penetrate a subject's skin located at the most proximal end of the skeleton, a base (404a) located at the end. opposite of the skeleton and an intermediate section (406a) connecting the base (404a) and sharp point section (402a). The base (404a), sharp point section (402a) and the intermediate section (406a) are connected to each other and/or integrally formed with each other. Each possibility represents a separate embodiment of the present invention. The base (404a) is in the shape of a cylinder, but can have other shapes, such as, but not limited to, a rectangular box, a cuboid, a triangular box, a polygonal box and the like. The base (404a) is attached to or integrally formed with the substrate (401a). Each possibility represents a separate embodiment of the present invention. The microneedle skeleton (400a) further comprises the pour restrictor (408a) in the form of a cone, situated between the sharp point section (402a) and the intermediate section (406a). The leakage restrictor (408) is in the form of a cone, but may have different shapes such as, but not limited to, a pyramid, triangular pyramid and the like.
[00160] The sharp-edged section (402a) is in the shape of a cone, but may have a different shape, such as, but not limited to, a pyramid, a triangular pyramid, or a polygonal pyramid. The pour restrictor (408a) is formed integrally with the sharp point section (402a) such that the cone base forming the leak restrictor (408a) is formed integrally with the cone base forming the sharp point section (402a) . The intermediate section (406a) is in the form of a longitudinal core extending substantially from the center of the sharp point section (402a) to the center of the base (404a). The middle section (406a) sends the extension (410a) through the base (404a) and into the substrate (401a). The middle part (116a) and the extension (410a) are perpendicular to the base (404a) and the substrate (401a). According to some embodiments, the perpendicular insertion of the intermediate section (406a) and the extension (410a) in the base (404) and the substrate (401a), respectively, gives stability to the microneedle (400a). The microneedle (400a) further comprises the skin enhancing composition (412a) surrounding the intermediate section (406a). The skin improving composition (412a) together with the mid section (406a) constitutes the middle part of the microneedle (400a). The Leak Restrictor (408a) is configured to prevent leakage of skin enhancement composition (412a) after extraction of the microneedle (400a) from a subject's skin. According to some embodiments, the skin enhancing composition (412a) comprises hydroxyapatite granules of about 40 µm and polyethylene glycol having a molecular weight of 20-50 kDa.
[00161] FIG. 4D shows the cross section (414) along line C-C of the middle part of the microneedle (400a). The cross section (414) shows the middle part (406a) of the skeleton and skin enhancing composition of the microneedle (412a). The line (d1) represents the diameter of the cross section (414). Note that the line (d1) represents the diameter of the central part of the microneedle (400a) at its widest part. FIG. 4E shows the cross section (418) along line D-D, of the sharp point section (402a). The line (d2) represents the diameter of the cross section (418). Note that the line (d2) represents the diameter of the sharp point section (402a) at its widest part. As can be seen in FIG. 4D and FIG. 4E, in accordance with the embodiment depicted in FIG. 4A, the diameter (d2) of the sharp point section (402) is larger than the diameter (d1) of the middle part of the microneedle (400). In accordance with some embodiments, a microneedle having a sharp-tipped section having a diameter greater than the diameter of the middle portion of the microneedle allows insertion of the microneedle into the skin of a subject without spillage of the skin enhancing composition outside the body.
[00162] FIG. 4B and FIG. 4C depict microneedles (400b) and (400c), respectively, in accordance with some embodiments of the invention. Sharp point sections (402b, 402c), intermediate sections (, 406b, 406c), leak restrictors (408b, 408c), extensions (410b, 410c) and microneedle augmentation compositions (412b, 412c) (400b, 400c) , respectively, and substrates (401b,401c) relate to each other essentially as described for the corresponding microneedle elements (400a). Microneedles (400b and 400c) are the same length as the microneedle (400a) depicted in FIG. 4A.
The base (404b) of the microneedle (400b) and the base (404c) of the microneedle (400c) have lengths h2 and h3, respectively, which are greater than the length h1 of the base (404a) depicted in FIG. 4A as part of the microneedle (400a). Base length h3 (404c) is greater than base length h2 (404b). Under some embodiments, a longer skeletal base is configured to prevent delivery of the skin enhancing composition to surface layers of the skin, such as, but not limited to, the epidermis. Under some embodiments, different areas of the skin require different lengths of microneedle bases due to differences in skin layer thickness, such as, but not limited to, the epidermis. In a non-limiting example, the microneedle (400c) can be used to treat an area of the skin having a thicker epidermal layer, while microneedles (400a) or (400b) can be used to treat an area of the skin having a thinner epidermal layer. .
[00164] FIGS. 5A - 5C show different microneedles in accordance with various embodiments of the present invention. FIG. 5A schematically shows the microneedle (500a) on the substrate (514a), in accordance with some embodiments of the invention. The microneedle (500) comprises a skeleton composed of: tip section (502a) integrally formed with the leakage restrictor (504a), base (510a) and an intermediate section composed of longitudinal core (506) and discs (508a, 508b) around the longitudinal core (506). The longitudinal core (506) is attached or integrally formed to the pour restrictor (504a). Each possibility represents a separate embodiment of the present invention. The microneedle (500) further comprises the skin enhancing composition (516a, 516b, 516c, 516d, 516e) surrounding the longitudinal core (506), between the discs (508a, 508b) and between the disc (508b) and the base (510a). The longitudinal core (506) sends the extension (512) through the base (510a) and the substrate (514a). The longitudinal core (506) is attached or integrally formed with the base (510a).
[00165] It should be understood that substrates (514b, 514c), as well as sharp point sections (502b,502c), leak restrictors (504b,504c) and microneedle bases (510b,510c) (518 and 528) , as described in FIGS. 5B, 5B' and 5C are essentially identical to corresponding elements (514a, 502a, 504a, 510a) of FIG. 5A.
[00166] FIG. 5B shows another embodiment of a microneedle in accordance with the present invention. FIG. 5B' shows an internal view of the microneedle of FIG. 5B. The middle section of the microneedle skeleton (518), as shown in FIGS. 5B and 5B', comprises a narrow longitudinal core (520) and a plurality of longitudinal stops (522) extending outwardly from the longitudinal core (520). The longitudinal stops (522) are attached or integrally formed to the pour restrictor (504b). Each possibility represents a separate embodiment of the present invention. The longitudinal stops (522) are attached or integrally formed to the base (510b). Each possibility represents a separate embodiment of the present invention. According to the embodiment shown in FIG. 5B, the skin enhancing composition (524) is located between the longitudinal stops (522). As described in FIG. 5B', the narrow longitudinal core (520) sends the narrow extension (526) through the base (510b) and to the substrate (514b).
[00167] The middle section of the microneedle skeleton (528), as shown in FIG. 5C, is composed of a rigid material (530) having a plurality of cavities (532). According to the embodiment shown in FIG. 5C, the skin enhancing composition (534) is located at least partially within cavities (532). In some embodiments, the rigid material (530) is attached or integrally formed in the base (510c). Each possibility represents a separate embodiment of the present invention. In some embodiments, the rigid material (530) is attached or integrally formed in the pour restrictor (504c). Each possibility represents a separate embodiment of the present invention. The rigid material (530) sends the extension (536) through the base (510c) and to the substrate (514c).
[00168] FIGS. 6A-D show the treatment of a line of skin or deep deficiency, using the applicator of the invention, according to various modalities. As described in FIG. 6A, the applicator (600) is positioned over and moved towards the skin deficiency (610). Skin deficiency (610) can be a deficiency in the skin, subcutaneous layers, or a combination of these. The applicator (600) comprises the substrate (602) and the microneedles (614a, 614b, 614c, 614d, 614e). Microneedles (614a and 614e) are of the same length and are shorter than microneedles (614b and 614d), which have the same length and are in turn shorter than microneedles (614c). The applicator (600) is positioned over the skin defect (610) such that longer microneedles (614b, 614c, 614d), substantially located in the center of the substrate (602), are positioned over the deepest point (612) of the deficiency of fur (610). Shorter microneedles (614a and 614e) are positioned over the shallower parts of the skin defect (610). In accordance with some embodiments, long microneedles (614c) are configured to deliver the skin enhancing composition (624c) to deeper skin layers or subcutaneously, such as, but not limited to, the hypodermis (608). In accordance with some embodiments, an applicator such as applicator (600) having microneedles (614a, 614b, 614c, 614d, 614e) of different lengths is configured to more uniformly increase a deep and/or non-uniformly formed skin deficiency such as skin deficiency (610). Each possibility represents a separate embodiment of the present invention. According to some modalities, the skin deficiency (610) is a nasolabial fold.
[00169] Each of the microneedles (614a, 614b, 614c, 614d, 614e) comprises a skeleton comprising three sections: base (616a, 616b, 616c, 616d, 616e), sharp point section (618a, 618b, 618c, 618d, 618e) configured to penetrate a subject's skin and integrally formed with the leak restrictor (620a, 620b, 620c, 620d, 620e) and intermediate section (622a, 622b, 622c, 622d, 622e) connecting the base (616a , 616b, 616c, 616d, 616e) and the pour restrictor (620a, 620b, 620c, 620d, 620e). Each of the intermediate sections (622a, 622b, 622c, 622d, 622e) sends the extension (626a, 626b, 626c, 626d, 626e) through bases (616a, 616b, 616c, 616d, 616e) and into the substrate (602 ). Each of the microneedles (614a, 614b, 614c, 614d, 614e) further comprises the skin enhancing composition (624a, 624b, 624c, 624d, 624e) surrounding the intermediate section (622a, 622b, 622c, 622d, 622e). Leak restrictors (620a, 620b, 620c, 620d, 620e) are configured to prevent leakage of the skin enhancement composition (624a, 624b, 624c, 624d, 624e) after extraction of the microneedles (614a, 614b, 614c, 614d, 614e) of a subject's skin.
[00170] The bases (614a and 614e) of the microneedles (614b and 614d), respectively, are of the same length and are shorter than the bases (616b and 616d) of the microneedles (614b and 616d) which have the same length and are in turn smaller than the base (616c) of the microneedle (614c). The base (616c) is long and configured to prevent delivery of the skin improving composition (624c) to the epidermis (604) and dermis layer (606), thus the microneedle (614c) delivers the skin improving composition (624c ) for deep layers such as, but not limited to, the hypodermis (608). The bases (616a, 616b, 616d, 616e) are configured to prevent delivery of the skin enhancing composition (624a, 624b, 624d, 624e) to the epidermis (604) and surface layers, as well as the microneedles (614a, 614b, 614d) , 614e) deliver the skin improving composition (624a, 624b, 624d, 624e) to sub-epidermal layers, such as, but not limited to, the dermis (606). According to some modalities, the length of the microneedle base is directly correlated with the thickness of the epidermis and/or other superficial layers to be penetrated by the microneedle. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the length of the microneedle base is directly correlated with the depth of the dermal or subdermal layer to which the composition of the invention is to be delivered. Each possibility represents a separate embodiment of the present invention. In some embodiments, the microneedle configured to deliver the composition to a subdermal layer comprises a longer microneedle base than a microneedle configured to deliver the composition to the dermis. In some embodiments, the length of the microneedle base is at least as long as the thickness of the epidermis and/or other surface layers to be penetrated by the microneedle. According to some modalities, the base of the microneedle is longer than the thickness of the epidermal layer to be penetrated by the microneedle. According to some embodiments, the applicator of the invention comprises microneedles of varying base lengths in correlation with the location of the microneedles in the substrate.
[00171] FIG. 6B depicts the applicator (600) after application to the skin deficiency (610). As can be seen in FIG. 6B, the substrate (602) is flexible and, after application, conforms to the contours of the skin deficiency (610). After application, the microneedles (614a, 614b, 614c, 614d, 614e) penetrated through the epidermis (604). Microneedles (614a, 614b, 614d, 614e) penetrate the dermis (606), while longer microneedles (614c) penetrate the lower layer (608), such as, but not limited to, the hypodermis. The length of the bases (616a, 616b, 616d, 616e) is greater than the thickness of the epidermis (604), thus preventing delivery of the skin enhancing composition (624a, 624b, 624d, 624e) to the epidermis (604). The base (616c) is as long as the thickness of the epidermis (604) and dermis (606) together, thus preventing delivery of the skin enhancing composition (624c) to the epidermis (604) and dermis (606).
[00172] FIG. 6C depicts the applicator (600) in the process of being removed from the skin deficiency (610) after treatment in accordance with some embodiments of the present invention. As can be seen in FIG. 6C, during the extraction of microneedles (614a, 614b, 614c, 614d, 614e) from the skin, at least a portion of the slides of the skin improvement composition (624a, 624b, 624c, 624d, 624e) slides over leak restrictors ( 620a, 620b, 620c, 620d, 620e) of microneedles (614a, 614b, 614c, 614d, 614e) and on the subject's skin. According to some embodiments, only the portion of the skin improving composition (624a, 624b, 624c, 624d, 624e) that did not biodegrade on the subject's skin during application slides over the leak restrictors (620a, 620b, 620c, 620d, 620e) of microneedles (614a, 614b, 614c, 614d, 614e) and in the skin or subcutis of the subject.
[00173] As can be seen in FIG. 6D, after the applicator (600) has been extracted from the subject's skin, the ameliorative composition (624a, 624b, 624d, 624e) remains within the dermis (606) and amelioration composition (624c) remains within the hypodermis (608) such that the skin deficiency (610) was increased. After extraction of the applicator (600) from the subject's skin, substrate (602) regains its original shape and comprises only the microneedle skeletons (614a, 614b, 614c, 614d, 614e).
[00174] FIGs, 7A-D show the treatment of a skin line or shallow deficiency, using the applicator of the invention, in accordance with various modalities. As described in FIG. 7A, the applicator (700) is positioned over and moved toward the skin deficiency (708). The applicator (700) comprises the substrate (702) and microneedles (710a, 710b, 710c, 710d). The microneedles (710a, 710b, 710, and 710d) of the applicator (700) all have substantially the same length and are configured to deliver the enhancing composition (714a, 714b, 714c, 714d) to the dermis (706) of the treated subject. .
[00175] Each of the microneedles (710a, 710b, 710c, 710d) comprise a skeleton comprising three sections: base (716a, 716b, 716c, 716d), sharp point section (720a, 720b, 720c, 720d) configured to penetrate the skin of a subject and integrally formed with the leak restrictor (718a, 718b, 718c, 718d) and intermediate section (712a, 712b, 712c, 712d) connecting the base (716a, 716b, 716c, 716d) and the leak restrictor (718a, 718b, 718c, 718d). Each of the intermediate sections (712a, 712b, 712c, 712d) sends the extension (722a, 722b, 722c,722d) through bases (716a, 716b, 716c, 716d) and to the substrate (702). Each of the microneedles (710a, 710b, 710c, 710d) further comprises the skin enhancing composition (714a, 714b, 714c, 714d) surrounding the intermediate section (712a, 712b, 712c, 712d). Leak restrictors (718a, 718b, 718c, 718d) are configured to prevent leakage of the skin enhancement composition (714a, 714b,714c, 714d) after extraction of the microneedles (710a, 710b,710c, 710d) from the skin of a subject.
[00176] FIG. 7B depicts the applicator (700) after application to the skin deficiency (708). As can be seen in FIG. 7B, the substrate (702) is flexible and, after application, conforms to the contours of the skin deficiency (708). After application, microneedles (710a, 710b, 710c, 710d) penetrate through the epidermis (704) and enter the dermis (706). According to some embodiments, the base (716a, 716b, 716c, 716d) of microneedles (710a, 710b, 710c, 710d) is as long as the thickness of the epidermis (704), thus preventing delivery of the enhancement composition ( 714a, 714b, 714c, 714d) to the dermis (704).
[00177] FIG. 7C depicts the applicator (700) in the process of being removed from the skin deficiency (708) after treatment in accordance with some embodiments of the present invention. As can be seen in FIG. 7C, during the extraction of microneedles (710a, 710b, 710c, 710d) from the skin, at least a part of the enhancement composition (714a, 714b, 714c, 714d) slides over the leak restrictor (718a, 718b, 718c, 718d ) from the microneedles (710a, 710b, 710c, 710d) and into the dermis (706).
[00178] As can be seen in FIG. 7D, after the applicator (700) has been extracted from the subject's skin, at least part of the ameliorative composition (714a, 714b, 714c, 714d) remains within the dermis (706) such that the skin deficiency (708) has been increased. According to some embodiments, only the biocompatible ceramic material that was present in the composition (714a, 714b, 714c, 714d) remains within the dermis (706). After extracting the applicator (700) from the subject's skin, the substrate (702) regains its original shape and comprises only the microneedle skeletons (710a, 710b, 710c, 710d).
[00179] FIGs. 8A-E schematically show a process for manufacturing microneedles, in accordance with some embodiments of the present invention. As shown in FIG. 8A, the first mold half (800) is loaded with a microneedle skeleton (801) comprising the sharp point section (802), the pour restrictor (804), the intermediate section (806), the base (808) and the extension (810). The sharp point section (802) may be bonded or integrally formed with the leak restrictor (804). In some embodiments, the extension (810) is the direct continuation of the middle section (806) projecting through the base (808). The first half-mold (800) is configured to delineate half of the middle part of the final needle to be produced. According to the embodiment shown in FIG. 8A, only the base (808) and the leak restrictor (804) of the microneedle skeleton (801) are in direct contact with the first mold half (800). In some embodiments, the extension (810), sharp point section (802) and part of the pour restrictor (804) protrude from the first mold half (800). In some embodiments, at least part of the base (808) protrudes from the first mold half (800). The first half-mold (800) is pictured as having a rectangular shape, but can be any shape that best suits the production of microneedles according to the modalities pictured. As shown in FIG. 8B, the enhancement composition (812) is deposited on the microneedle skeleton (801) such that it covers the intermediate section (806) and part of the pour restrictor (804). As shown in FIG. 8C, the second mold half (814) is mounted on the first mold half (800) and the microneedle skeleton (801) on which the enhancement composition has been deposited. When assembled around the microneedle skeleton (801) on which the enhancement composition has been deposited, the first mold half (800) and second mold half (814) are configured to delineate the intermediate part of the microneedle such that the The resulting microneedle enhancement composition will surround the midsection (806) and at least part of the leak restrictor (804). The first mold half (800) and the second mold half (814) are configured to shape the intermediate portion of the produced microneedle into a desired shape. In some embodiments, the first mold half (800) and the second mold half (814) are configured to braid together in part. As seen in FIG. 8D, the enhancement composition (812), which defines an intermediate part of the microneedle produced, is in the form of a cylinder after removal of the second half-mold (814), but can be in other shapes, such as a polygonal box, as provided by the first half-mold (800) and the second half-mold (814). FIG. 8E depicts the final microneedle as produced in accordance with the embodiments of FIGs. 8A-E. The extension (810) can be inserted into a substrate of an applicator in accordance with the present invention. Extension (810) may be cut to accommodate a substrate in accordance with the present invention, either before or after being inserted into the substrate.
[00180] According to other modalities (not shown), the first half-mold (800) is loaded with microneedle skeleton(801), followed by deposition of enhancement composition (812) in the middle section part (806) and leakage restrictor (804) such that only the parts of the middle section (806) and the exhaust plug (804) which are inside the first mold half (800) are filled with improvement composition (812). excess enhancement composition (812) can be removed. After the enhancement composition (812) that was deposited on the first mold half (800) has dried, additional enhancement composition can be added on top of the dry enhancement composition followed by accommodation of the second mold half (814) on the first half-mold (800). After the enhancement composition has fully dried, the first mold half (800) and second mold half (814) can be removed, resulting in the final microneedle, as depicted in FIG. 8E.
[00181] According to another aspect, the present invention provides a method for manufacturing a microneedle for administering a skin improvement composition to a skin and/or subcutis of a subject, the method comprises: producing a skeleton of microneedle of a rigid material, said skeleton comprising: a sharp point section located at one end of said skeleton, said sharp point section being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting said sharp point section and said base; and depositing a skin enhancement composition on said skeleton such that said enhancement composition at least partially surrounds said intermediate section, and a diameter of said sharpened section is greater than a diameter of said enhancement composition; wherein said composition comprises at least one biocompatible ceramic material.
[00182] According to some embodiments, depositing the skin improving composition according to the method for manufacturing the present invention comprises preventing deposition of the skin improving composition around the sharp point and base section.
[00183] According to some embodiments, the method for manufacturing the present invention further comprises placing the microneedle skeleton in a mold prior to depositing the skin enhancement composition, wherein the mold is configured to mold the enhancement composition of skin around at least part of the middle section. In some embodiments, the mold is additionally configured to prevent deposition of the skin enhancing composition around the base and sharp point section.
[00184] According to some embodiments, the present invention provides a method of manufacturing the microneedles of the invention, the method comprises depositing a skin improving composition around at least part of the intermediate section of the microneedle such that the sharp point section and the microneedle base remain devoid of the skin enhancing composition. According to some embodiments, the manufacturing method further comprises depositing the skin enhancing composition around at least a portion of a pour restrictor. According to some embodiments, the method for manufacturing the present invention comprises placing the microneedle skeleton in a mold such that the mold is configured to mold the composition around at least part of the intermediate section, and wherein the mold is configured not to deposit the skin enhancement composition surrounding the base and sharp tip section of the microneedle. In some embodiments, the mold is configured to mold the skin enhancing composition surrounding at least part of the intermediate section and at least part of the pour restrictor. In some embodiments, the mold is composed of a plurality of parts, such as, but not limited to, a first and a second mold half.
[00185] According to another aspect, the present invention provides a method for delivering a skin improving composition to a skin defect or deficiency, comprising placing in place an applicator configured for administering a skin improving composition. for a subject's skin, the applicator comprising a substrate and an array of microneedles, wherein the substrate has a generally flat structure having two opposing surfaces, wherein one surface is intended to be placed proximally to the one subject's skin and the other surface facing away from the subject's skin; wherein the microneedle array is located on the proximal surface of the subject's skin, the array comprising a multiplicity of microneedles, wherein each of the microneedles comprises: a skeleton made of a rigid material, the skeleton comprising: a sharp-tipped section , located at one of the ends of said skeleton, said sharp point section being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin enhancement composition comprising at least one biocompatible ceramic material, wherein said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharpened section is greater than a diameter of said enhancement composition. .
[00186] According to another aspect, the present invention provides a method for filling a fold, wrinkle, line or depressed area in a subject, comprising placing in place of the fold, wrinkle, line or depressed area an applicator configured for the administration of an enhancement composition, the applicator comprising a substrate and an array of microneedles, wherein the substrate has a generally flat structure having two opposing surfaces, wherein one surface is intended to be placed proximally to the skin of one subject and the other surface, facing away from the subject's skin; wherein the microneedle array is located on the proximal surface of the subject's skin, the array comprising a multiplicity of microneedles, wherein each of the microneedles comprises: a skeleton made of a rigid material, the skeleton comprising: a sharp-tipped section , located at one of the ends of said skeleton, said sharp point section being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin enhancement composition comprising at least one biocompatible ceramic material, wherein said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharpened section is greater than a diameter of said enhancement composition. .
[00187] According to some embodiments, the present invention provides a method for delivering a skin-enhancing composition to a site of skin defect or deficiency, comprising placing in place an applicator configured for administering an ameliorative composition. from skin to skin of a subject, the applicator comprising a substrate and an array of microneedles, wherein the substrate has a generally flat structure having two opposing surfaces, wherein one surface is intended to be placed in such a manner. proximal on a subject's skin and the other surface facing away from the subject's skin; wherein the microneedle array is located on the proximal surface of the subject's skin, the array comprising a multiplicity of microneedles, wherein each of the microneedles comprises: a skeleton made of a rigid material, the skeleton comprising: a sharp-tipped section , located at one of the ends of said skeleton, said sharp point section being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin improving composition comprising granules and/or particles of hydroxyapatite or a salt or derivatives, wherein the improving composition at least partially surrounds the intermediate section, such that a diameter of the sharpened section is greater than the diameter. of the improvement composition. Each possibility represents a separate embodiment of the present invention.
[00188] Under some embodiments, unwanted crease, wrinkle, line or depressed area refers to unwanted crease, wrinkle, line or depressed area in skin, subcutaneous layers or a combination thereof. Each possibility represents a separate embodiment of the present invention. In some embodiments, skin defect or deficiency refers to a defect or deficiency in the skin, subcutaneous layers, or a combination thereof. Each possibility represents a separate embodiment of the present invention. According to some embodiments, the method of the invention comprises placing in place an applicator configured for administering a skin-improving composition to a subject's skin or subcutaneous layers of a subject or a combination thereof. Each possibility represents a separate embodiment of the present invention.
[00189] According to some embodiments, the present invention provides a method for filling a fold, wrinkle, line or depressed area in a subject, comprising placing in place of the fold, wrinkle, line or depressed area an applicator configured for the administration of an enhancement composition, the applicator comprising a substrate and an array of microneedles, wherein the substrate has a generally flat structure having two opposing surfaces, wherein one surface is intended to be placed proximally to the skin of one subject and the other surface, facing away from the subject's skin; wherein the microneedle array is located on the proximal surface of the subject's skin, the array comprising a multiplicity of microneedles, wherein each of the microneedles comprises: a skeleton made of a rigid material, the skeleton comprising: a sharp-tipped section , located at one of the ends of said skeleton, said sharp point section being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin improving composition comprising granules and/or particles of hydroxyapatite and/or a salt or derivatives, wherein the improving composition at least partially surrounds the intermediate section, such that a diameter of the sharp point section is greater than the diameter of the enhancement composition. Each possibility represents a separate embodiment of the present invention.
[00190] According to some embodiments, the present invention provides an applicator configured for administering a skin improvement composition to a subject's skin and/or subcutis for use in filling a crease, wrinkle, line or area. depressed in a subject, the applicator comprising a substrate, wherein the substrate has a flattened structure generally having two opposing surfaces, wherein one surface is intended to be placed proximally to a subject's skin and the other surface facing away from the subject's skin; and a microneedle array, wherein the microneedle array is located on the proximal surface of the subject's skin, the array comprising a multiplicity of microneedles, each of the microneedles comprising: a skeleton made of a rigid material, the skeleton comprising : a sharp point section, located at one of the ends of said skeleton, said sharp point section, being configured to penetrate a subject's skin; a base on an opposite end of said skeleton; and an intermediate section connecting between said sharp point section and said base; and a skin enhancement composition comprising at least one biocompatible ceramic material, wherein said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharpened section is greater than a diameter of said enhancement composition. .
[00191] According to some embodiments, the methods of the invention are useful for delivering a skin-improving composition to a site of skin defect or deficiency. Under some embodiments, the place of the skin defect or deficiency is lines, wrinkles, unwanted wrinkles and the like on a subject's skin. According to some modalities, the place of the skin defect or deficiency is lines, wrinkles, unwanted wrinkles and the like on a subject's facial skin. In some embodiments, the methods of the invention are useful for filling in an unwanted crease, wrinkle, line, or depressed area in a subject. Each possibility represents a separate embodiment of the present invention.
[00192] As used herein, the terms "placement" and "administration" are used interchangeably and refer to locating the applicator of the invention in a desired place. According to some embodiments, after administration, the microneedles penetrate the treatment area and the composition of the invention is delivered to the place of destination. In a non-limiting example, placing the applicator over a forehead wrinkle results in insertion of the microneedles into the subject's skin and delivery of the composition of the invention into the dermal and/or subdermal layer. According to some embodiments, after placing the applicator on a subject's skin, the microneedles penetrate the skin and the biodegradable polymer and/or salt undergo biodegradation, thus releasing the biocompatible ceramic, which remains in the subject after removal of the applicator.
[00193] According to some modalities, the place of the skin defect or deficiency is the place of a scar. In some embodiments, the terms "treated area" and "treatment area" are interchangeable and refer to a site of defect or deficiency in the skin or subcutis or a combination thereof. Each possibility represents a separate embodiment of the present invention. According to some modalities, the site of the skin or subcutis defect or deficiency is the site of a depressed scar. Each possibility represents a separate embodiment of the present invention. In some embodiments, the methods of the invention are useful in improving scarring. According to other embodiments, the methods of the invention are useful in filling scar tissue in the skin and/or subcutis. Each possibility represents a separate embodiment of the present invention. As used herein, the term "normal skin" refers to healthy skin and/or youthful looking skin.
[00194] Examples of non-limiting a place of defect or skin or subcutis defect that can be treated by the applicator of the invention, according to some modalities, may include: delicate forehead, cheek, neck, nasal bridge and wrinkles in the lip, nasolabial folds, puppet lines, depressed scars, lips, malar bone area and a combination of these. Each possibility represents a separate embodiment of the present invention.
[00195] According to some modalities, the applicator is placed in a place of defect or skin deficiency, or in lines, wrinkles, unwanted folds for at least 1, 2, 3, 5, 6, 7, 8, 9, 10, 11, 12 hours. Each possibility represents a separate embodiment of the present invention. According to some modalities, the applicator is placed in a place of defect or deficiency of the skin, or in lines, wrinkles, unwanted folds for at least one whole night. As used here, an entire night is between 6-10 hours. According to some modalities, the applicator is placed in a place of defect or deficiency in the skin, or in lines, wrinkles, unwanted folds for at least 24 hours. Each possibility represents a separate embodiment of the present invention. According to some modalities, the applicator is placed in a place of defect or skin deficiency, or in lines, wrinkles, unwanted folds for at least 1, 2, 3, 5, 6, 7 days. Each possibility represents a separate embodiment of the present invention. According to some modalities, the applicator is placed in a place of defect or skin deficiency, or in lines, wrinkles, unwanted folds for a period of time sufficient for the degradation of the biodegradable carrier. Typically, the applicator is placed on a spot of defect or deficiency on the skin, or on unwanted lines, wrinkles, creases for 24-72 hours.
[00196] According to some embodiments, the skin enhancing composition is a slow release skin improving composition. As used herein, the term "slow release skin improving composition" refers to a composition configured for slow release of a skin improving material and/or a drug or toxin. Each possibility represents a separate embodiment of the present invention. In a non-limiting example, the applicator of the invention comprising a slow-release skin enhancing material is placed on the subject's face for several days. According to this non-limiting example, the applicator can induce the slow release and slow delivery of the skin enhancement material, thus achieving a more efficient target site improvement. i
[00197] According to some modalities, the subject places the applicator of the invention in a desired place. According to some embodiments, the applicator of the invention remains in a desired location for a desired period of time through the use of an adhesive. As used herein, the adhesive is inert, biologically compatible and allows for easy removal from the applicator of the invention. According to some embodiments, the adhesive is water resistant. In some embodiments, the adhesive is located only on the inner surface portion of the substrate. In some embodiments, the applicator of the invention is water resistant. According to some modalities, the applicator is molded like an adhesive bandage so that it can be placed discreetly on the subject's face for a desired time. According to some embodiments, the applicator of the invention can be affixed to the treatment area using external fixation aid such as, but not limited to, a bandage, a handkerchief and the like.
[00198] Under some arrangements, the applicator is removed after a desired period of time. In some embodiments, the desired time period depends on the types of microneedles and skin-improving compositions used in the applicator, the amount of composition used, the treatment site, the desired effect, and a combination thereof. Each possibility represents a separate embodiment of the present invention.
[00199] According to some embodiments, after removal of the applicator, at least part of the skin-improving composition remains at the site of administration, while the skeletons of the microneedles are removed with the applicator. According to some embodiments, after removal of the applicator, at least a part of the biocompatible ceramic remains in place of administration, while the microneedle skeletons are removed with the applicator.
[00200] According to some embodiments, the invention provides a kit comprising at least one of the applicators of the invention and instructions for using the applicator. Under some embodiments, the applicators, methods and kits of the invention can be used by the subject without the need for assistance from a person providing medical care. Under some embodiments, the applicators, methods and kits of the invention do not require surgical intervention. According to some embodiments, the methods of the invention are used to fill in the lines, wrinkles, depressed scars and unwanted creases in the face of a subject without the use of needles or surgical intervention. Each possibility represents a separate embodiment of the present invention.
[00201] According to some embodiments, the method of the invention would have to be repeated several times in order to fill a locus of skin defect or deficiency. According to other embodiments, a single use of the applicator of the invention is sufficient to fill a skin defect or deficiency spot. According to some embodiments, the dimensions and/or shape of the location of the skin defect or deficiency determines how many times the applicator of the invention would have to be used in the same location as the skin defect or deficiency in order to achieve the desired filling. Each possibility represents a separate embodiment of the present invention. In a non-limiting example, a deep and/or wide and/or irregularly shaped skin defect or deficiency may require multiple repetitions of the method of the invention and/or multiple applicators of the invention and/or a longer application time for proper filling of the defect or skin deficiency. Each possibility represents a separate embodiment of the present invention.
[00202] As used herein, the terms "subject", "a subject in need" and "a patient in need" are used interchangeably and refer to a subject in need of skin or subcutis improvement or a combination of these. Under some embodiments, the subject is a subject having unwanted lines, wrinkles and folds such as, but not limited to, elderly people. According to other modalities, the subject is a subject having a scar in need of improvement or filling. In a non-limiting example, a subject is a subject having facial wrinkles that he or she would like to be filled in for healthier, fuller looking facial skin. As a note, a subject may have normal looking skin and want to use the applicator/method of the invention to achieve a fuller skin appearance in a desired area, such as, but not limited to, the cheeks and lips.
[00203] As used herein, the term "about" refers to +M0%, preferably +/-5%, more preferably +/-1%. Each possibility represents a separate embodiment of the present invention.
[00204] As used in this document, the terms "sub cutaneous" and "sub cutaneous" are used interchangeably. It is to be understood that the applicator and/or microneedles of the invention are configured for administering a skin or subcutaneous layer enhancing composition or a combination thereof. It is to be understood that the methods of the invention provide enhancement or filling of skin or sub-cutaneous layers or a combination thereof.
[00205] According to some embodiments, the present invention provides a use of the applicator of the invention for skin improvement in a subject in need. In accordance with some embodiments, the present invention provides a use of the applicator of the present invention for filling an unwanted crease, wrinkle, line, or depressed area on the skin of a subject in need.
[00206] The above description of specific modalities will so completely reveal the general nature of the invention that others may, through the application of current knowledge, readily modify and/or adapt such specific modalities for various applications without undue experimentation and without straying from the generic concept and, therefore, such adaptations and modifications must and are intended to be understood within the meaning and range of equivalents of the disclosed modalities. It should be understood that the phraseology or terminology used in this document is for the purpose of description and not limitation. The means, materials and steps for carrying out the various functions disclosed can take a variety of alternative forms without departing from the invention. EXAMPLES Example 1: Treatment of delicate forehead wrinkles
[00207] An applicator comprising a substrate in the form of a strip, comprises an array of microneedles with a skin augmentation composition such as RADIESSE®. The applicator is placed on a delicate forehead wrinkle and adheres to the subject's face, using an adhesive surface included on the substrate surface that is proximal to the skin. The applicator is kept on the subject's skin for a period of time as desired by the user, caregiver or as instructed by the applicator's instructions. Example 2: Treatment of a nasolabial fold
[00208] An applicator comprising a substrate in the form of a flap is placed in a nasolabial fold. Applicator microneedles comprise skeletons having a cylindrical base, an intermediate section in the form of a cylindrical longitudinal core and a tapered sharp point section. The skeleton further comprises a cone-shaped leakage restrictor, formed integrally with the sharpened point section. The mid-skeletal section of each microneedle is surrounded by a skin augmentation composition. The skin augmentation composition is composed of hydroxyapatite granules (40μm), polyethylene glycol (40 kDa) and magnesium sulfate granules. The applicator adheres to the subject's face, using an adhesive surface included on the substrate surface that is proximal to the skin. The applicator is kept on the subject's skin for a period of time as desired by the user, caregiver or as instructed by the applicator's instructions. The applicator is removed along with the microneedle skeletons, while the skin enhancing composition remains within the treated area. Example 3: Preparation of an enhancement composition comprising hydroxyapatite
[00209] Hydroxyapatite (100gr) is dispersed in molten polyethylene glycol (PEG-20000) using vigorous stirring. Next, a concentrated magnesium sulphate solution is prepared by dissolving 30g of magnesium sulphate in hot water and the hot solution is added to the molten PEG solution with constant mixing. The mixture is mixed until it cools and becomes a paste.
[00210] The above description of specific modalities will so completely reveal the general nature of the invention that others may, through the application of current knowledge, readily modify and/or adapt such specific modalities for various applications without undue experimentation and without straying from the generic concept and, therefore, such adaptations and modifications must and are intended to be understood within the meaning and range of equivalents of the disclosed modalities. It should be understood that the phraseology or terminology used in this document is for the purpose of description and not limitation. The means, materials and steps for carrying out the various functions disclosed can take a variety of alternative forms without departing from the invention. It should be understood that additional tests are being performed to establish clinical effects.

权利要求:
Claims (16)
[0001]
1. Applicator (100, 200, 300, 600, 700) configured for administering a skin improvement composition to a skin and/or subcutis of a subject, said applicator characterized in that it comprises: a substrate (102, 202, 302, 401a, 401b, 401c, 514a, 514b, 514c, 602, 702), wherein said substrate has a generally flat structure having two opposing surfaces (104, 106; 210, 212; 304, 306 ), wherein one surface (104, 210, 304) is to be placed proximally on a subject's skin and the other surface (106, 212, 306) facing away from the subject's skin; and a microneedle array (108, 214, 308), in which the microneedle array is located on the surface proximal to the subject's skin, the array comprising a plurality of microneedles (110a, 110b, 110c and 110d); (216a, 216b, 216c, 216d, and 216e); (310a, 310b, 310c, 310d and 310e); (400a, 400b, 400c), (500a, 518, 528) (614a, 614b, 614c, 614d, 614e), (710a, 710b, 710c, 710d) in which each of said microneedles comprises: a skeleton (801) made of a rigid material, said skeleton comprising: a sharp point section (112a, 112b, 112c, 112d) (220a, (220b, 220c, 220d, 220e), (402a, 402b, 402c), (502a, 502b, 502c) (618a, 618b, 618c, 618d, 618e), (720a 720b, 720c, 720d), (802) located at one end of said skeleton, said sharp point section, being configured to penetrate a subject's skin ; a base (114a, 114b, 114c and 114d) (222a, 222b, 222c, 222d and 222e) (404a 404b, 404c), (510a, 510b,510c) (616a, 616b, 616c, 616d, 616e), ( 714a, 714b, 714c, 714d) (808) over an opposite end of said skeleton; and an intermediate section (116a, 116b, 116c, 116d), (224a,224b, 224c, 224d, and 224e) (406a, 406b, 406c), (622a, 622b, 622c, 622d, 622e), (712a, 712b, 712c, 712d) (806) connecting between said sharp point section and said base; and a composition of skin improvement (122a, 122b, 122c, 122d) (230a, 230b, 230c, 230d, 230e) (412a, 412b, 412c) (516a, 516b, 516c, 516d, 516e), (624a, 624b, 624c, 624d, 624e), (714a, 714b, 714c, 714d) (812) comprising at least one biocompatible ceramic material, in which said enhancement composition at least partially surrounds said intermediate section, such that a diameter of said sharp point section is greater than a diameter of said enhancement composition and wherein a length of said base is equal to or greater than a thickness of an epidermis in a treated area and wherein the base and sharp point section of each of the microneedles do not comprise the skin increase makeup.
[0002]
2. Applicator according to claim 1, characterized in that said sharp point section, said base and said intermediate section are integrally formed.
[0003]
3. Applicator according to claim 1, characterized in that said skeleton further comprises a leakage restrictor (118a, 118b, 118c, 118d), (226a, 226b, 226c, 226d,226d, 226e), ( 408a, 408b, 408c), (504a, 504b, 504c), (620a, 620b, 620c, 620d,620e), (718a, 718b, 718c, 718d) (804) wherein the leakage restrictor is located between said sharp-edged section and said intermediate section; and wherein said leak restrictor is configured to prevent leakage of said skin enhancing composition from said subject after extraction of said microneedle from said subject's skin.
[0004]
4. Applicator according to claim 3, characterized in that said leak restrictor is formed integrally with said sharp tip.
[0005]
5. Applicator according to claim 1, characterized in that said base section and/or said intermediate section has a shape selected from the group consisting of: a cylinder, a rectangular box, a cuboid, a box triangular and a polygonal box; and wherein said nose section has a shape selected from the group consisting of: a cone, a pyramid, a triangular pyramid and a polygonal pyramid.
[0006]
6. Applicator according to claim 1, characterized in that said intermediate section is a longitudinal core substantially extending from the center of said sharp point section to the center of said base.
[0007]
7. Applicator according to claim 1, characterized in that said biocompatible ceramic material is in the form of particles.
[0008]
8. Applicator according to claim 1, characterized in that said enhancement composition further comprises at least one type of skin enhancement material selected from the group consisting of: a natural biodegradable substance, a biodegradable synthetic polymer, a non-biodegradable synthetic polymer, a non-biodegradable natural substance, and combinations thereof.
[0009]
9. Applicator according to claim 1, characterized in that said improvement composition comprises a biodegradable vehicle.
[0010]
10. Applicator according to claim 1, characterized in that said enhancement composition further comprises a biologically active agent selected from a group consisting of: an enzyme, a drug, a toxin and a combination thereof .
[0011]
11. Applicator according to claim 1, characterized in that: said skeleton (801) is attached to said substrate surface intended to be attached to the skin of a subject; said skeleton is configured to be fully inserted into the skin; the skeletal base of the microneedle and sharp point section are configured to remain devoid of the skin augmentation composition and to prevent delivery of the skin augmentation composition to the epidermis or epidermis and upper dermis; and the length of said base section of each of said microneedles is selected in correlation with the location where said microneedle is configured to be situated within the treated area.
[0012]
12. Applicator according to claim 1, characterized in that said skeleton (801) is formed integrally with said substrate surface intended to be placed proximal to the skin of a subject.
[0013]
13. Applicator according to claim 1, characterized in that said skeleton (801) is at least partially inserted in said substrate.
[0014]
14. Applicator according to claim 1, characterized in that at least part of the surface that is intended to be placed proximal to the subject's skin is an adhesive surface.
[0015]
15. Use of an applicator as defined in any one of claims 1 to 14, characterized in that it is for filling an unwanted crease, wrinkle, line or depressed area on the skin and/or subcutaneous tissue of an individual.
[0016]
16. Microneedle (110a, 110b, 110c and 110d); (216a, 216b, 216c, 216d, and 216e); (310a, 310b, 310c, 310d and 310e); (400a, 400b, 400c), (500a, 518, 528) (614a, 614b, 614c, 614d, 614e), (710a, 710b, 710c, 710d) for administering a skin augmentation composition to a skin and/ or subcutis of a subject, characterized in that the microneedle comprises: a skeleton (801) made of a rigid material, the skeleton characterized in that it comprises: a sharp-tipped section (112a, 112b, 112c,112d) ( 220a, (220b, 220c, 220d, 220e), (402a, 402b, 402c), (502a, 502b, 502c) (618a, 618b, 618c, 618d, 618e), (720a, 720b, 720c, 720d), (802) ) located at one end of said skeleton, the sharp point section being configured to penetrate the subject's skin; a base (114a, 114b, 114c and 114d) (222a, 222b, 222c, 222d and 222e) (404a 404b, 404c ), (510a, 510b, 510c) (616a, 616b, 616c, 616d, 616e), (714a, 714b, 714c, 714d) (808) at the opposite end of said skeleton; and an intermediate section (116a, 116b, 116c , 116d), (224a,224b, 224c, 224d, and 224e) (406a, 406b, 406c), (622a, 622b, 622c, 62 2d, 622e), (712a, 712b, 712c, 712d) (806) connecting between said sharp point section and the base; and a skin improving composition (122a, 122b, 122c, 122d) (230a, 230b, 230c, 230d, 230e) (412a, 412b, 412c) (516a, 516b, 516c, 516d, 516e), (624a, 624b) , 624c, 624d, 624e), (714a, 714b, 714c, 714d) (812) comprising at least one biocompatible ceramic material, wherein the augmentation composition at least partially surrounds the central section, so that a diameter of said section a sharp point is greater than a diameter of said augmentation composition and wherein a length of said base is equal to or greater than a thickness of an epidermis in a treated area and wherein the base and sharp point section of the microneedle do not comprise the skin increase makeup.

类似技术:

---

公开号 | 公开日 | 专利标题

---

BR112015005073B1|2021-06-01|APPLICATOR CONFIGURED FOR THE ADMINISTRATION OF A SKIN IMPROVEMENT COMPOSITION TO A SUBJECT'S SKIN AND/OR SUBCUTIS, USE OF A MICRONEEDLE AND METHOD TO MANUFACTURE A MICRONEEDLE

---

Jacovella2008|Use of calcium hydroxylapatite | for facial augmentation

---

JP2020529909A|2020-10-15|Implants and medical safety features including enhanced anchoring

---

US9993334B1|2018-06-12|Hair implants comprising enhanced anchoring and medical safety features

---

JP2020529909A5|2021-09-09|

---

KR20180109914A|2018-10-08|Surgical sutures for skin-enlargement

---

US20200009364A1|2020-01-09|Microneedles and compositions for skin augmentation

---

US10561490B2|2020-02-18|Hair implants comprising enhanced anchoring and medical safety features

---

IL275855D0|2020-08-31|High-load microneedles and compositions for skin augmentation

---

BR112018013756B1|2021-11-03|SURGICAL SUTURE

---

TW202100113A|2021-01-01|Hair implants comprising enhanced anchoring and medical safety features

---

US20220061981A1|2022-03-03|Hair implants comprising enhanced anchoring and medical safety features

---

US20220061982A1|2022-03-03|Hair implants comprising enhanced anchoring and medical safety features

---

Goldberg2010|BIOALCAMID®

同族专利:

---

公开号 | 公开日

---

US10420921B2|2019-09-24|

---

CN104661695A|2015-05-27|

---

JP6546091B2|2019-07-17|

---

AU2013316706A1|2015-03-05|

---

EP2895217A4|2016-08-03|

---

ES2851234T3|2021-09-03|

---

CN104661695B|2019-02-15|

---

WO2014041531A1|2014-03-20|

---

EP2895217B1|2020-10-21|

---

CA2883055A1|2014-03-20|

---

CN110025881A|2019-07-19|

---

IL237462A|2020-07-30|

---

CA2883055C|2021-02-09|

---

JP2015531644A|2015-11-05|

---

HK1210728A1|2016-05-06|

---

US20150209563A1|2015-07-30|

---

EP2895217A1|2015-07-22|

---

AU2013316706B2|2018-06-21|

---

IL237462D0|2015-04-30|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US7060287B1|1992-02-11|2006-06-13|Bioform Inc.|Tissue augmentation material and method|

---

AT208217T|1992-02-28|2001-11-15|Cohesion Tech Inc|INJECTABLE, CERAMIC COMPOUNDS AND METHOD FOR THE PRODUCTION AND USE THEREOF|

---

US6579516B1|1995-06-13|2003-06-17|Zahra Mansouri|Methods of delivering materials into the skin, and compositions used therein|

---

AU6505601A|2000-05-26|2001-12-11|Procter & Gamble|Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup|

---

JP4090018B2|2002-02-18|2008-05-28|ＦｏｒＨｅａｄ株式会社|Functional micropile and manufacturing method thereof|

---

WO2003092785A1|2002-04-30|2003-11-13|Morteza Shirkhanzadeh|Arrays of microneedles comprising porous calcium phosphate coating and bioactive agents|

---

US20060177494A1|2005-01-31|2006-08-10|Micheal Cormier|Coated microprojections having reduced variability and method for producing same|

---

US20080262444A1|2005-01-31|2008-10-23|Bioserentach Co., Ltd.|Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment|

---

US20080213461A1|2005-06-17|2008-09-04|Georgia Tech Research Corporation|Coated Microstructures and Methods of Manufacture Thereof|

---

US20070224252A1|2006-03-27|2007-09-27|Trautman Joseph C|Microprojections with capillary control features and method|

---

CN101553275A|2006-08-29|2009-10-07|纳生微电子有限公司|High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances|

---

JP4954656B2|2006-09-28|2012-06-20|凸版印刷株式会社|Acicular body and method for producing acicular body|

---

WO2008072229A2|2006-12-12|2008-06-19|Nanopass Technologies Ltd.|Methods for dermal filling using microneedles|

---

JP2008284318A|2007-05-15|2008-11-27|Kosumedei Seiyaku Kk|Microneedle for dosing, including living body origin matter|

---

WO2009051147A1|2007-10-18|2009-04-23|Hisamitsu Pharmaceutical Co., Inc.|Microneedle device|

---

JP5179976B2|2008-07-08|2013-04-10|富士フイルム株式会社|Needle seat manufacturing method|

---

CN102325563A|2008-12-22|2012-01-18|昆士兰大学|Patch production|

---

US20120264689A1|2009-10-07|2012-10-18|Genogen, Inc.|Methods and compositions for skin regeneration|

---

EP2338557A1|2009-12-23|2011-06-29|Debiotech S.A.|Soluble microneedle|

---

ES2663095T3|2010-03-19|2018-04-11|Cosmed Pharmaceutical Co., Ltd.|Matrix of microneedles containing proteoglycan|

---

BR112013022949A2|2011-03-07|2016-12-06|3M Innovative Properties Co|microneedle device and methods|

---

KR20150003745A|2012-04-25|2015-01-09|데이진 가부시키가이샤|Microneedle and microneedle array|

---

US9044582B2|2012-06-26|2015-06-02|Franklin J. Chang|Apparatus and method for transdermal fluid delivery|

---

TWI554289B|2012-06-29|2016-10-21|國立成功大學|Embeddable patch for transdermal drug delivery and method of manufacturing the same|US20050249899A1|2004-05-06|2005-11-10|Bonutti Peter M|Biodegradable packaging material|

---

US10159825B2|2009-09-17|2018-12-25|Zipline Medical, Inc.|Rapid closing surgical closure device|

---

US10123801B2|2011-11-01|2018-11-13|Zipline Medical, Inc.|Means to prevent wound dressings from adhering to closure device|

---

EP2579828B1|2010-06-14|2018-06-13|Zipline Medical Inc.|Apparatus for inhibiting scar formation|

---

US10123800B2|2011-11-01|2018-11-13|Zipline Medical, Inc.|Surgical incision and closure apparatus with integrated force distribution|

---

US9561034B2|2011-11-01|2017-02-07|Zipline Medical, Inc.|Surgical incision and closure apparatus|

---

EP3025754B1|2013-07-22|2020-09-30|Toppan Printing Co., Ltd.|Needle-shaped body|

---

JP2017502762A|2014-01-05|2017-01-26|ジップライン メディカル， インコーポレイテッドＺｉｐｌｉｎｅ Ｍｅｄｉｃａｌ， Ｉｎｃ．|Wound closure device with equipment|

---

CA2943215A1|2014-03-28|2015-10-01|Allergan, Inc.|Dissolvable microneedles for skin treatment|

---

EP3148630A4|2014-05-28|2018-03-14|Chee Yen Lim|A flexible dissolvable patch|

---

MX2017010383A|2015-02-13|2018-11-12|Endo Derma Co Ltd|Microstructure using cross-linked hyaluronic acid hydrogel, and method for producing same.|

---

US20160279401A1|2015-03-27|2016-09-29|Allergan, Inc.|Dissolvable microneedles for skin treatment|

---

CN107427474A|2015-04-13|2017-12-01|株式会社Lg生活健康|The soluble micropin of composition containing regulation neurotransmitter regulator|

---

JP6760288B2|2015-07-17|2020-09-23|凸版印刷株式会社|Transdermal administration device|

---

CA2991455A1|2015-07-24|2017-02-02|Kimberly-Clark Worldwide, Inc.|Methods for better delivery of active agents to tumors|

---

CN105434332A|2015-12-02|2016-03-30|江汉大学|Preparation method for water-soluble biological macromolecular microneedle membrane|

---

CN105641801B|2016-02-27|2019-01-01|浙江理工大学|A kind of porous hydroxyapatite/gelatin-compounded microneedle array patch and preparation method thereof|

---

KR20170115429A|2016-04-07|2017-10-17|랩앤피플주식회사|Micro needle Using the Bioabsorbable Metal|

---

JP6900405B2|2016-06-16|2021-07-07|エンドダーマ カンパニー リミテッドＥｎｄｏｄｅｒｍａ Ｃｏ．，Ｌｔｄ．|Hyaluronic acid microstructure with excellent dissolution properties|

---

CN106187126B|2016-06-30|2019-01-25|北京百纳美迪生物科技有限公司|A kind of ceramics micropin chip and preparation method thereof|

---

WO2018081795A1|2016-10-31|2018-05-03|Zipline Medical, Inc.|Systems and methods for monitoring physical therapy of the knee and other joints|

---

EP3498330A4|2016-12-29|2020-04-29|Labnpeople Co.,Ltd.|Micro needle|

---

EP3582752A1|2017-02-17|2019-12-25|Allergan, Inc.|Microneedle array with active ingredient|

---

US20210060321A1|2018-01-07|2021-03-04|Avraham Amir|High-load microneedles and compositions for skin augmentation|

---

TWI698263B|2018-07-19|2020-07-11|淡江大學|Method for manufacturing micro-needle device and method for manufacturing micro-needle mold|

---

US20210308440A1|2018-09-24|2021-10-07|L'oreal|Device comprising microneedles for skin-coloring|

---

CN111558128A|2019-03-26|2020-08-21|华中科技大学同济医学院附属协和医院|Soluble microneedle array carrying scar repairing medicine and preparation method|

---

JP6866902B2|2019-03-29|2021-04-28|凸版印刷株式会社|Cell transplant system|

---

EP3950025A1|2019-03-29|2022-02-09|Toppan Printing Co., Ltd.|Cell transplantation device and cell transplantation system|

---

JP6828764B2|2019-03-29|2021-02-10|凸版印刷株式会社|Cell transplant device|

---

KR102290268B1|2019-10-11|2021-08-13|부산대학교 산학협력단|implantable substance delivery system, and preparation method of thereof|

---

CN111569153A|2020-06-04|2020-08-25|童艳梅|Application of thin strip-shaped acellular dermal matrix|

法律状态:
2018-12-04| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|

---

2019-11-26| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

---

2021-03-23| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

---

2021-06-01| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/06/2013, OBSERVADAS AS CONDICOES LEGAIS. |

优先权:

---

申请号 | 申请日 | 专利标题

---

US201261700371P| true| 2012-09-13|2012-09-13|

---

US61/700,371|2012-09-13|

---

US201261721037P| true| 2012-11-01|2012-11-01|

---

US61/721,037|2012-11-01|

---

US201261725498P| true| 2012-11-13|2012-11-13|

---

US61/725,498|2012-11-13|

---

PCT/IL2013/050510|WO2014041531A1|2012-09-13|2013-06-13|Delivery devices and methods for skin augmentation|

---